Endorsement of Statement of the Committee on Free Expression and Free Inquiry 11723

Appointment/Reappointments to The University of Virginia’s College at Wise Board 11735

Establishment of the John and Barbara Glynn Professorship in Venture Capital 11736

Establishment of the Quantitative Foundation Bicentennial Professorship of Education 11738

New Degree Program: Doctor of Philosophy in Computational Biology in the School of

Degree Program Discontinuation: Education Specialist in Administration and Supervision

Financing Plans for the Chemistry Building Fume Exhaust Renewal, Massie Road Utility

2021-2022 Operating Budget for The University of Virginia's College at Wise 11740

2021-2022 Operating and Capital Budgets for the University of Virginia Medical Center 11740

Issuance of General Revenue Pledge Bonds as Part of the University's Capital Project

2021 Major Capital Plan for the Academic Division, UVA Health, and the College at Wise 11747

Election of Ms. Robyn S. Hadley as Vice President and Chief Student Affairs Officer 11764

Re-Election of Virginia H. Evans as Vice President and Chief Information Officer 11764

Following the meetings of seven committees of the Board, the Board of Visitors of the University of Virginia met as the full Board in open session at 12:50 p.m. on Friday, June 4, 2021. James B. Murray Jr., Rector, presided. Open session was streamed live.

Present and participating were Robert M. Blue, Mark T. Bowles, L.D. Britt, M.D., Whittington W. Clement, Frank M. Conner III, Elizabeth M. Cranwell, Thomas A. DePasquale, Barbara J. Fried, John A. Griffin, Louis S. Haddad, Robert D. Hardie, Maurice A. Jones, Babur B. Lateef, M.D., Angela Hucles Mangano (via Zoom), C. Evans Poston Jr., James V. Reyes, Ellen M. Bassett, and Sarita Mehta.

Also present were James E. Ryan, Jennifer Wagner Davis, K. Craig Kent, M.D., M. Elizabeth Magill, Margaret S. Grundy, Susan G. Harris, Timothy J. Heaphy, Donna P. Henry, Michael J. Citro, John C. Jeffries Jr., Megan K. Lowe, Mark Luellen, David Martel, Clark L. “Chip” Murray, Melur K. Ramasubramanian, and Debra D. Rinker.

In addition to President Ryan, the executive vice presidents, and members of the Board, Joel W. Hockensmith also presented.

The Rector called the meeting to order, welcomed the new student representative, Sarita Mehta, and directed Visitors to the agenda contained in the written materials. On motion, the Minutes of the March 3-5, 2021 regular meeting of the Board of Visitors and the April 13, 2021 and May 17, 2021 special meetings of the Board of Visitors were approved by unanimous voice vote.

APPROVAL OF THE MINUTES OF THE MARCH 3-5, 2021 REGULAR MEETING, APRIL 13, 2021 AND MAY 17, 2021 ELECTRONIC MEETINGS OF THE BOARD OF VISITORS

RESOLVED, the Board of Visitors approves the minutes of the March 3-5, 2021 Regular Meeting, April 13, 2021, and May 17, 2021 Electronic Meetings of the Board of Visitors.

Rector Murray reviewed the consent agenda items. On motion, the following resolutions were approved by unanimous voice vote:

RESOLVED, the Board of Visitors approves the consideration of addenda to the published Agenda.

RESOLVED, Pavilion VI, East Lawn, is assigned to Ms. Robyn S. Hadley, Vice President and Chief Student Affairs Officer, for a period of five years, commencing summer 2021.

RESOLVED, Montebello is assigned to Ms. Jennifer L. West, Dean, School of Engineering and Applied Science, for a period of five years, commencing summer 2021.

WHEREAS, the White Burkett Miller Center of Public Affairs (the Miller Center) is a department of the University and its Governing Council has certain responsibilities concerning the Miller Center; and

WHEREAS, the Board of Visitors elects members of the Governing Council on nomination by the Governing Council; and

WHEREAS, the Governing Council has nominated by unanimous vote four individuals for election to the Council;

RESOLVED, the Board of Visitors approves the appointments of four individuals to the Governing Council of the White Burkett Miller Center of Public Affairs for three-year terms commencing July 1, 2021: Mary Vee Connell, Pete Geren, John Harris, and Tricia Hoefling.

WHEREAS, the Board of Visitors may appoint up to six non-voting public members to the Health System Board (or its successor) with initial terms not to exceed four years and eligibility for reappointment to an additional term;

RESOLVED, William G. Crutchfield Jr. of Charlottesville, VA is reappointed as a public member of the Health System Board or its successor. Mr. Crutchfield’s term is for two years, commencing July 1, 2021 and ending on June 30, 2023.

RESOLVED, Kenneth Botsford, M.D. of Birmingham, Alabama is appointed as a public member of the Health System Board or its successor. Dr. Botsford’s term is for four years, commencing July 1, 2021 and ending on June 30, 2025.

The Rector made brief remarks about Mr. Butcher, Mr. Farrell, Mr. Griffin, and Ms. Bassett, and asked Visitors to read the commending and memorial resolutions. Mr. Clement read the memorial resolution for Robert G. Butcher, Mr. Blue read the memorial resolution for Thomas F. Farrell II, the Rector read the commending resolution for John A. Griffin, and Ms. Cranwell read the commending resolution for Ellen M. Bassett. On motion, duly seconded, all four resolutions were approved by unanimous voice vote.

WHEREAS, Robert G. “Butch” Butcher Jr. was a double ‘Hoo, taking his undergraduate degree from the College of Arts & Sciences in 1957 and a law degree in 1960; and

WHEREAS, as an undergraduate, Butch Butcher was a member of Phi Kappa Sigma fraternity, Eli Banana, and president of the P.K. German Dance Society, which booked bands for social events; and

WHEREAS, Mr. Butcher practiced law in Richmond with Parrish, Butcher, and Parrish, and then with Browder, Russell, and Morris, which later became Browder, Russell, Little, Morris, and Butcher; and

WHEREAS, in 1974 he and others founded Investors Savings and Loan, colloquially known as the “squirrel bank”, and later he became its chairman and CEO; and

WHEREAS, Mr. Butcher’s interest in real estate development led to the founding of Builder Resource and Development, where he served as president; and

WHEREAS, Butch enjoyed athletics, especially UVA athletics, and served as president of the Virginia Student Aid Foundation, now known as the Virginia Athletics Foundation, or VAF. In 2005 he was awarded the Order of the Crossed Sabres for outstanding service to UVA Athletics; and

WHEREAS, Mr. Butcher was appointed to the Board of Visitors by Governor Baliles in 1988, and reappointed by Governor Wilder in 1992; and

WHEREAS, among other duties on the Board, Mr. Butcher was chair of the Finance Committee and served on the Executive Committee; and

WHEREAS, as a member of the Board of Visitors, Butch was known for speaking his mind, having little patience for process but preferring to get to the heart of an issue, and for his thorough enjoyment of all kinds of jokes, including practical jokes; and

RESOLVED, the Board of Visitors commemorates the life and many accomplishments of Robert G. Butcher Jr., particularly his dedicated service to the University of Virginia; and

RESOLVED FURTHER, the Board extends its sincerest condolences to his children Robert (A&S ’82), Laura (A&S ’85), Guy (A&S ’90), and Kevin, and their spouses, his stepsons and their spouses, and his beloved grandchildren, as well as his many friends and colleagues.

WHEREAS, Thomas F. Farrell II was a double ‘Hoo, taking his undergraduate degree in economics from the College and Graduate School of Arts & Sciences in 1976 and a law degree in 1979; and

WHEREAS, as an undergraduate, Tom Farrell received the prestigious Pete Gray award, now known as the Gray-Carrington Award, the highest honor an undergraduate can receive; and as a law student he was a Dillard Fellow; and

WHEREAS, Mr. Farrell left the private practice of law in 1995 to join Dominion Resources, where he held several executive management positions before assuming the CEO position in 2006. A day before his passing he retired from his final position as chair of the Dominion Board of Directors; and

WHEREAS, Mr. Farrell’s service to the University and related entities was extensive and remarkable. He served on many boards, including the Miller Center Governing Council and the boards of the McIntire Foundation, the Miller Center Foundation, the Jefferson Scholars Foundation, the Darden School Foundation, the College at Wise, the College Foundation, and the UVA Foundation; and

WHEREAS, a history buff, especially Virginia history, Mr. Farrell was an active co-chair of the University’s Bicentennial Commission as well as chair of the Colonial Williamsburg Foundation board, and he wrote and produced a film about a Civil War battle entitled “The Field of Lost Shoes”; and

WHEREAS, Mr. Farrell was also active in the Richmond community and statewide, serving on numerous boards and commissions, often as chair. He chaired the Richmond Performing Arts Alliance, and served on the Virginia Commonwealth University Board of Visitors, the Virginia Museum of Fine Arts Board of Trustees, and the State Council of Higher Education for Virginia; and

WHEREAS, Mr. Farrell was appointed to the Board of Visitors by Governor Gilmore in 2001 and he was reappointed by Governor Warner in 2005; and

WHEREAS, Mr. Farrell was elected vice rector in 2003 and became Rector of the University in 2005; and

WHEREAS, when he became Rector, Mr. Farrell remarked that he lives by four words: duty, honor, country, and family; and

WHEREAS, as Rector, Mr. Farrell imposed discipline on Board committees requiring annual work plans and goals; worked with the administration on a ten-year financial plan; and restructured the University of Virginia Investment Management Company as a separate corporate entity to manage the University’s endowment; and

WHEREAS, Mr. Farrell sought to improve the structure of the fundraising foundations and their relationship with the University through a special committee led by Mac Caputo and Leonard Sandridge; and

WHEREAS, Mr. Farrell was a highly effective, focused leader who had a no-nonsense approach to getting to the heart of an issue and making decisions quickly and decisively; and

WHEREAS, University leadership, as well as leaders from around the Commonwealth, regularly sought Tom Farrell’s wise counsel and good company; and

WHEREAS, Mr. Farrell’s wife, Anne Garland, an alumna of the College and an active member of the University community, chronicled many University events through her stunning photographs; and

RESOLVED, the Board of Visitors commemorates the extraordinary life and accomplishments of Thomas Francis Farrell II, particularly his dedicated service to the University of Virginia; and

RESOLVED FURTHER, the Board extends its sincerest condolences to his wife, Anne Garland, his two sons Peter (A&S ’06) and Stuart (Comm ’07) and their spouses, and his beloved grandchildren as well as many friends and colleagues.

WHEREAS, John A. Griffin took a B. S. in Commerce with a concentration in Finance from the McIntire School of Commerce in 1985, and a M.B.A. from the Stanford University Graduate School of Business in 1990; and

WHEREAS, Mr. Griffin began his very successful career in finance as an analyst for Morgan Stanley Merchant Banking Group in 1985, and moved to Tiger Management in 1987 where he served as an analyst and portfolio manager before becoming president in 1993; and

WHEREAS, Mr. Griffin founded iMentor.org, a nonprofit online mentoring organization, and the Blue Ridge Foundation, which created Blue Ridge Labs, now a part of the Robin Hood Foundation. He currently serves as board chair at iMentor and the Robin Hood Foundation and is a board member at the Julian H. Robertson Foundation. He also serves as chair of the University of Virginia McIntire School of Commerce Foundation Board; and

WHEREAS, Mr. Griffin teaches at the McIntire School of Commerce as a visiting professor. Courses have included Practical Behavioral Finance, The Analyst's Edge, and Deciding Wisely and Thinking Critically: How to Thrive in a Complex, Uncertain World; and

WHEREAS, Mr. Griffin and his wife Amy, an alumna of the College and Graduate School of Arts & Sciences, are generous donors to several areas of the University including the McIntire School of Commerce where he endowed the deanship among other gifts; Athletics; and the Blue Ridge Scholars program, which Mr. Griffin founded to provide financial assistance to undergraduates with exceptional academic promise and significant financial need; and

WHEREAS, Mr. Griffin was appointed to the Board of Visitors by Governor McDonnell in 2013 and reappointed by Governor McAuliffe in 2017; and

WHEREAS, Mr. Griffin’s contributions to the work of the Board of Visitors are numerous and important, including as co- chair and then chair of the Advancement Committee, and chair of the Finance Committee. He championed the Bicentennial Scholars and Bicentennial Professors matching programs, led the effort on a new funding model for Advancement, and chaired a Finance subcommittee charged with developing a financial pricing model that promoted a number of goals including affordability, predictability, and diversity and inclusiveness; and

WHEREAS, Mr. Griffin’s significant knowledge of finance and philanthropy as well as his ability to quickly digest and explain very complex issues in simple, layman’s terms has made him an invaluable member of the Board; and

WHEREAS, Mr. Griffin will complete his term on the Board of Visitors on June 30, 2021;

RESOLVED, the Board of Visitors thanks John A. Griffin for his engaged and exemplary service to the Board and to the University, considers him a friend and valued colleague, and hopes and expects that he will continue to be engaged in the work of the University; and

RESOLVED FURTHER, his colleagues on the Board wish John and Amy Griffin continued success and happiness in all of their future endeavors.

WHEREAS, Ellen M. Bassett took a A.B. degree with distinction in history and political science from the University of Michigan-Ann Arbor as well as a M.A. in history and an M.S. and Ph.D. in urban and regional planning from the University of Wisconsin-Madison; and

WHEREAS, Ms. Bassett has worked at the University of Virginia in the School of Architecture since 2012 as a faculty member in urban and environmental planning, and she is currently the chair of the department; and

WHEREAS, Ms. Bassett’s main area of expertise is international development, and particularly land tenure and property rights issues in African cities that grew out of her time as a Peace Corps volunteer in Kenya in the 1990s; and

WHEREAS, Ms. Bassett has been active in faculty governance at the University, serving two terms on the UVA Faculty Senate first as a member and then as its chair; and

WHEREAS, Ms. Bassett was appointed the faculty representative to the Board of Visitors effective July 1, 2020, for a one-year term; and

WHEREAS, Ms. Bassett has been an active and engaged member of the Academic and Student Life Committee, the Finance Committee, and the Committee on The University of Virginia’s College at Wise; and

WHEREAS, Ms. Bassett‘s keen insight on faculty issues have helped the Board make informed decisions;

RESOLVED, the Board of Visitors thanks Ellen M. Bassett for her exceptional service and wise counsel to the University and the Board, considers her a trusted friend and colleague, and wishes her continued success and happiness in all of her future endeavors.

President Ryan began by reporting the success of 2021 Final Exercises amidst the COVID-19 pandemic, with the Class of 2020 and 2021 able to hold in-person final exercises that included a procession from the Rotunda to Scott Stadium at the Carl Smith Center. The ceremonies, seven of them in total, included both in person and virtual speeches and performances. Professor Melody Barnes was the keynote speaker for the 2020 ceremonies, and alumnus Alexis Ohanian was the keynote for 2021. He then moved to free speech issues at the University, and how a diverse committee was formed in January 2021 that included University leaders, students, and professors - to ensure that the expression of different viewpoints remains integral to the UVA learning experience. The committee developed a statement favoring open expression of all viewpoints in every aspect of university life which was endorsed unanimously. The Board voted to affirm the statement.

On motion, duly seconded, the following resolution was approved by the Board. The full Statement of the Committee on Free Expression and Free Inquiry follows the resolution.

ENDORSEMENT OF STATEMENT OF THE COMMITTEE ON FREE EXPRESSION AND FREE INQUIRY

WHEREAS, in February 2021 President Ryan and Provost Magill formed a committee charged with articulating the University’s commitment to free expression and free inquiry and the role these play in the academic enterprise, that expresses the University’s values, its history, and its legal obligations; and

WHEREAS, the composition of the Committee on Free Expression and Free Inquiry (the Committee) includes individuals with widely divergent viewpoints and experiences; and

WHEREAS, following several listening sessions engaging members of the University and Charlottesville communities, the Committee developed the attached statement, which is endorsed by all of the members of the Committee and President Ryan and Provost Magill; and

WHEREAS, the Statement of the Committee on Free Expression and Free Inquiry (the Statement) notes that Thomas Jefferson’s “vision for the University included the aspiration that ‘here we are not afraid to follow truth wherever it may lead, nor to tolerate any error so long as reason is left free to combat it’”; and

WHEREAS, the Committee also notes that as a public university, the University is bound by the Constitution, including the First Amendment; and

WHEREAS, the Committee’s statement includes a recognition that the University may regulate the time, place and manner of expression “for reasons unrelated to its content, including maintaining the normal operations of the University” and that “[f]ree expression also does not protect speech that violates the law;” and

WHEREAS, the Statement sets forth the University’s position on free expression and free inquiry and suggests how we might act in accordance with our aspirations, as follows:

The University of Virginia unequivocally affirms its commitment to free expression and free inquiry. All views, beliefs, and perspectives deserve to be articulated and heard free from interference. This commitment underpins every part of the university’s mission. Free and open inquiry is the basis for the scientific method and all other modes of investigation that produce, expand, and refine knowledge. It is at the heart of the principles of academic freedom that protect faculty from interference with their research and their views. Likewise, the educational endeavor for students requires freedom to speak, write, inquire, listen, challenge, and learn, including through exposure to a range of ideas and cultivation of the tools of critical thinking and engagement. These tools are vital not only to students’ personal intellectual development but also to their futures as citizen leaders equipped to assess contending arguments and to contribute to societal progress. For all of these reasons, expression of ideas should be given the widest possible latitude…

Free and open inquiry inevitably involves conflicting views and strong disagreements. Indeed, some ideas may be offensive, noxious, and even harmful. We act as responsible members of a shared community when we engage as empathetic speakers and generous listeners. We further our common project of academic inquiry with mutual respect and intellectual openness. Even as the University affirms values of mutual respect, however, both the First Amendment and principles of free inquiry forbid these values from becoming a basis for closing off discussion. The University must not stifle protected expression, permit others to obstruct or shut down such expression, or regulate the tone or content of responses that stop short of interfering with others’ speech or violating the law. Rather than seek to control speech or countenance its silencing, the University must promote values of mutual respect, while emphasizing that their vitality rests with the self-governance of speakers and listeners.

RESOLVED, the Board of Visitors unequivocally endorses the Statement of the Committee on Free Expression and Free Inquiry; and

RESOLVED FURTHER, the Board thanks the members of the Committee for their impressive efforts in gathering input and crafting an eloquent and concise statement.

We endorse principles of free expression and free inquiry not because every idea is equally good. To the contrary, universities test and assess ideas every day, through myriad processes of research and inquiry. These processes identify errors and generate breakthroughs of immense value for local, national, and global communities. Indeed, the University has endeavored to acknowledge its own complex legacy while promoting the free exchange of ideas that creates future advances and progress. Academic commitment to free inquiry reflects the view that every idea must be heard so that it may be subjected to the rigorous scrutiny necessary to advance knowledge. This process requires deep critical engagement, as well as humility in the recognition that many commonly accepted views have proved mistaken, while many ostracized views have illuminated the path toward truth.

The University of Virginia has a unique connection to principles of free expression and inquiry. James Madison introduced the Bill of Rights, including what is now the First Amendment, as a member of Congress representing the district that would become home to the University. James Madison and Thomas Jefferson’s Virginia and Kentucky Resolutions were among the earliest extended interpretations of the First Amendment, which, as the Supreme Court observed years later, “carried the day in the court of history” and “first crystallized a national awareness of the central meaning of the First Amendment.”¹ Jefferson’s vision for the University included the aspiration that “here we are not afraid to follow truth wherever it may lead, nor to tolerate any error so long as reason is left free to combat it.”²

At the same time, the University has not always fulfilled its aspirations, exploiting enslaved laborers and excluding Black Americans, women, and groups and viewpoints disfavored by the majority. Principles of academic freedom have not always withstood the pressures and fashions of the day, which remains an ongoing challenge. But freedom of speech is among the most powerful tools by which wrongs are righted and institutions are improved or abolished. Principles of free inquiry extend to robust discussion and critical examination of the past. Equally importantly, they live in the present and extend to the future, in a shared commitment to free expression for all speakers and all views.

The University’s commitment to free expression and free inquiry arises not only from its role as an academic institution but also from its status as a public university. State institutions are bound by the Constitution, including the First Amendment. As Justice Thurgood Marshall wrote for the Supreme Court, “To permit the continued building of our politics and culture, and to assure self-fulfillment for each individual, our people are guaranteed the right to express any thought, free from government censorship.”³ Actions by the University implicate not only academic values but also this legal principle and the ideals behind it.

Under American law, principles of free expression have important limits. The University may regulate the time, place, and manner of expression for reasons unrelated to its content, including maintaining the normal operations of the University. Free expression also does not protect speech that violates the law, including legally defined categories of incitement, defamation, threats, privacy violation, and intellectual property infringement. In addition, various types of prohibited conduct can be partially or entirely composed of speech, including stalking, harassment, and unlawful discrimination. These exceptions are defined by law and represent narrow and necessary limits to an otherwise expansive commitment.

The University’s commitment to free expression and free inquiry represents a living ideal, reflected in policy and embodied in the actions of community members every day. We rearticulate and reaffirm it here, as a foundation for the University’s third century and beyond.

Leslie Kendrick, vice dean of the School of Law, director of the Center for the First Amendment, Chair

Rita Dove, Henry Hoyns Professor of Creative Writing and former U.S. Poet Laureate

Susan Kirk, M.D., professor and associate dean for Graduate Medical Education and chair-elect of the Faculty Senate

Joel Gardner, alumnus (A&S ’70, LAW ’74) and author of From Rebel Yell to Revolution: My Four Years at UVA 1966-1970

John Griffin, Investor, visiting scholar at the School of Commerce, member, Board of Visitors

Kevin McDonald, vice president for diversity, equity, inclusion, and community partnerships

Mazzen Shalaby, Batten School graduate student and student representative to the Board of Visitors

President Ryan reviewed the progress of the 2030 Strategic Plan. The strategic plan has 4 goals: strengthen UVA’s foundation, cultivate the most vibrant community in higher education, enable discoveries that enrich and improve lives, and make UVA synonymous with service. The 10 key initiatives are dynamic ways in which these goals can be met, and Mr. Ryan demonstrated the website dashboard’s status tracker of each initiative, along with a new Timeline tool.

He stated that expanding Second Year housing is in the exploration stage, establishing the Data Science school is in the intermediate stage, and creating a new community engagement office is in the complete stage. He also listed several accomplishments regarding the Plan: approved designs for buildings at Emmet-Ivy; established new community partnerships and scholarships; met community healthcare needs during the pandemic; and began paying a Living Wage to all employees. Funding for the 2030 Strategic Plan comes from the strategic investment fund, philanthropy, and matching funds.

The Thomas Jefferson Awards were conferred by President Ryan and Provost Magill. Because they were not awarded in 2020, they conferred four awards this year, two for scholarship and two for service. These prestigious awards are given to members of the University community who exemplify in character, work, and influence the principles and ideals of Thomas Jefferson and thus advance the objectives for which he founded the University.

Provost Magill presented the awards for scholarship to Willam A. Petri, M.D. and Professor Dennis R. Proffitt. Dr. Petri is a leading expert on GI illnesses and infections. He has been at UVA for over 40 years. During the pandemic, he played a role in vaccine development, educated the public, mentored students and physicians, and much more. Dr. Petri said a few words of thanks and remarked that although Jefferson failed both personally and politically by not abolishing slavery, the words he wrote in the Declaration of Independence defined democracy and are still creating a positive stress between what the country was defined as and what it is today.

Dennis Proffitt, Commonwealth Professor of Psychology emeritus. His research has been around how a person’s physical state influences the person’s perceptions of the world, and how the way a person perceives the world translates into action. He has had a 40-year career at UVA. He is one of the most cited individuals in the field of cognitive psychology. He is a popular teacher and mentor. His scholarship has shaped the study of psychology. Professor Proffitt gave brief remarks thanking the Department of Psychology, his students, his wife an evolutionary biologist, and the University. He said undergraduates at UVA “are like nowhere else.”

President Ryan presented the awards recognizing excellence in service to Senior Vice President for Operations and State Governmental Relations Colette Sheehy, and former dean of the McIntire School of Commerce Carl Zeithaml. He said Ms. Sheehy was one of the two first female vice presidents at UVA. She began work at UVA in 1982 and has worked her way through the budget and finance areas. Ms. Sheehy is well respected in state government as well. Ms. Sheehy spoke briefly and thanked those who made her career possible, particularly former Executive Vice President Leonard Sandridge.

Dean Zeithaml was honored by President Ryan, who said his 23-year leadership of the McIntire School profoundly transformed the school. Dean Zeithaml thanked the Alumni Board of Trustees for their support of the award, and he said he had the pleasure of spending one third of his life working and living at the University. He said his accomplishments were made possible by his “two families”—McIntire and his wife, Charlotte, and their children.

Rector Murray said UVA is coming out of a very difficult time and did it successfully. He thanked the Board and leadership. He asked for a round of applause for leadership.

The Rector recognized the lifetime achievement award given to Dr. Britt from the American College of Surgeons, and said the Board is proud to claim Dr. Britt as a member. He highlighted accomplishments at UVA including funding the Institute of Democracy, which should prove to be one of UVA’s signature achievements of the next decade; the importance of the statement from the Committee on Free Expression and Free Inquiry; and the Democracy Dialogues, which are a laudable first step to re-establishing a culture of open-mindedness.

The Rector said the decision to repatriate sacred objects from the Kluge/Ruhe aboriginal art collection is important to note. He also remarked on progress on initiatives in northern Virginia; the phenomenal performance of the University of Virginia Investment Management Company (UVIMCO), which enables the bond offering without risking the triple A bond rating; the creation of a data dashboard; the affordable housing initiative moving forward with requests for proposals going out this fall; athletics successes this year amid the pandemic, including national championships; and a planned debt sale that should position the University well for many years.

Ms. Mehta spoke primarily about student advising. She said that student advising should be a priority at the University. Currently, advisors and students in the College of Arts & Sciences are matched through decisions such as COLA enrollment, which results in a lack of uniform support for tailored career advising. Additionally, many students and advisors only interact semesterly, which will pose greater problems post-pandemic, as students have larger gaps in academic preparedness and knowledge of opportunities for involvement on-Grounds.

She stated that essential skills with which UVA students should graduate include navigating the increasingly competitive job market, interviewing well, and experiencing intellectual growth, all of which can be strengthened through restructuring advising. She emphasized that UVA has a wealth of resources for mentorship and career advising, so these tools should be used cohesively with official academic advising.

Mr. Hockensmith outlined the structural changes, accomplishments, and dynamics of the Faculty Senate for the past year. The Faculty Senate structural changes, partially driven by the COVID-19 pandemic, were the following: new inclusion of procedural guidelines (quorum, parliamentarian, etc.); electronic voting; and streamlined deliberative processes, all helping with better communication and representation. Regarding this year’s Faculty Senate accomplishments, there were a number of resolutions regarding racial equity; the creation of a Handbook of the Faculty Senate in order to write and record policies; and Open Access Guidelines to assure equitable distribution of advanced knowledge by the University. Lastly, Mr. Hockensmith remarked that there was greater consensus among senators this year than in the past, with 85% of members supporting COVID vaccination requirements for students, and other voting items receiving large majorities.

Total fundraising progress for the University of Virginia and its related foundations was $321,132,589 through March 31, 2021. Gifts and commitments to the Darden School of Business, Alumni Association, School of Continuing and Professional Studies, Miller Center, Architecture School, School of Leadership and Public Policy, and the Center for Politics saw increases over the previous fiscal year.

At 3:10 p.m., Mr. Haddad read the closed session motion, and after approving the motion, the voting members present and the faculty and student representatives to the Board met in closed session. James E. Ryan, Jennifer Wagner Davis, K. Craig Kent, M.D., Margaret Grundy, Susan G. Harris, Timothy J. Heaphy, M. Elizabeth Magill, John C. Jeffries Jr., Mark M. Luellen, David Martel, Michael Citro, Anda Webb, and Debra D. Rinker also participated in parts of the closed session.

“I move that the Board of Visitors go into Closed Session to consult with legal counsel and receive legal advice about specific legal and regulatory matters including potential and actual litigation; to discuss and consider elections, appointments, promotions, salaries, resignations, and retirements of specific officers and employees; to discuss the annual evaluation of the president; to discuss appointment of individuals to lead initiatives in northern Virginia and to discuss specific UVA Health business development, joint venture, and marketing strategies in the northern Virginia area. The relevant exemptions are Sections 2.2‐3711 A (1), (6), (7), (8) and (22) of the Code of Virginia.”

At 4:22 p.m., the Board resumed in open session, and, on motion duly seconded, certified that the deliberations in closed session had been conducted in accordance with the exemptions permitted by the Virginia Freedom of Information Act. Ms. Harris called the roll, and all members present voted in the affirmative: Mr. Murray, Mr. Blue, Mr. Bowles, Dr. Britt, Mr. Clement, Mr. Conner, Ms. Cranwell, Mr. DePasquale, Ms. Fried, Mr. Griffin, Mr. Haddad, Mr. Hardie, Mr. Jones, Dr. Lateef, Ms. Mangano, Mr. Poston, and Mr. Reyes.

“That we vote on and record our certification that, to the best of each member’s knowledge, only public business matters lawfully exempted from open meeting requirements and which were identified in the motion authorizing the Closed Session, were heard, discussed or considered in Closed Session.”

All voting members were present. Mr. Murray reminded the members of the Board that the consent and action items were presented in committee except as otherwise stated.

President Ryan read the titles of the action items. The Rector then read the titles of the following two resolutions. On motion, duly seconded, the consent and action items as well as the resolutions discussed in closed session, were approved by unanimous voice vote.

RESOLVED, Robert D. Hardie is appointed Vice Rector for a two-year term commencing July 1, 2021, after which he will assume the Rectorship for a two-year term.

2021-2022 SALARY FOR PRESIDENT JAMES E. RYAN

RESOLVED, the Board of Visitors approves the following 2021-2022 compensation and accrued bonus for the President of the University of Virginia:

President James E. Ryan

1. APPOINTMENT/REAPPOINTMENTS TO THE UNIVERSITY OF VIRGINIA’S COLLEGE AT WISE BOARD

(approved by the Committee on The University of Virginia’s College at Wise on June 3, 2021)

RESOLVED, Dr. J. Scott Litton is appointed to The University of Virginia’s College at Wise Board for a period of four-years, ending June 30, 2025, in accordance with the UVA Wise College Board bylaws; and

RESOLVED FURTHER, Mr. Leton L. Harding, Jr., Mr. Lewey K. Lee, Jr., Mr. Robert F. Stallard, and Mr. Jeffery A. Sturgill are reappointed to The University of Virginia's College at Wise Board for four-year terms ending June 30, 2025, in accordance with the UVA Wise College Board bylaws.

(approved by the Audit, Compliance, and Risk Committee on June 3, 2021 – See Attachment A for Audit Plan)

RESOLVED, the Audit Department FY 2022-FY 2023 Audit Plan is approved as recommended by the Audit, Compliance, and Risk Committee.

(approved by the Audit, Compliance, and Risk Committee on June 3, 2021 – See Attachment B for changes to the Charter)

RESOLVED, changes to the Audit Department Charter are approved as recommended by the Audit, Compliance, and Risk Committee.

4. ESTABLISHMENT OF THE JOHN AND BARBARA GLYNN PROFESSORSHIP IN VENTURE CAPITAL

WHEREAS, John W. Glynn Jr. (LL.B. ’65), MacAvoy Professor of Business Administration, teaches the Venture Capital course at the Darden School of Business. Mr. Glynn also serves as a member of the Darden School Foundation Board of Trustees, and is a founder and general partner with Glynn Capital Management and Glynn Ventures, a venture capital firm in Menlo Park, California; and

WHEREAS, Barbara A. Glynn, who took an M.A. in History from the Graduate School of Arts & Sciences in 1967, is a founding member of The Tech Interactive (formerly The Tech Museum of Innovation), a family-friendly science and technology center in San Jose, California, and a College Foundation emeritus trustee; and

WHEREAS, the Glynns provided funds to establish three endowed professorships at the University including one at the Darden School of Business for a distinguished scholar in the field of venture capital which will be matched by the University through the Bicentennial Professors Fund;

RESOLVED, the Board of Visitors establishes the John and Barbara Glynn Professorship in Venture Capital at the Darden School of Business; and

RESOLVED FURTHER, the Board of Visitors offers profound thanks to John and Barbara Glynn for their very generous contributions of time and resources to the Darden School of Business and the University of Virginia.

WHEREAS, John W. Glynn Jr. (LL.B. ’65) and his wife, Barbara A. Glynn (A&S M.A. ’67), endowed and named the John W. Glynn Jr. Law & Business Program at the School of Law, which integrates courses on business and legal analysis to prepare students for their professional careers; and

WHEREAS, The Glynns provided funds to establish three endowed professorships at the University with one at the School of Law. Along with matching funds provided by the University through the Bicentennial Professors Fund, the Glynn Family Bicentennial Professorship in Law will support a faculty member teaching in the area of law and business at the School of Law;

RESOLVED, the Board of Visitors establishes the Glynn Family Bicentennial Professorship in Law at the School of Law; and

RESOLVED FURTHER, the Board of Visitors offers profound thanks to John and Barbara Glynn and the Glynn Family for their very generous contributions of time and resources to the School of Law and the University of Virginia.

WHEREAS, Mark E. Galant and Cynthia Terry Galant, as well as their daughter, Kendall E. Galant, are graduates of the University, Mr. Galant from the McIntire School of Commerce and Mrs. Galant and their daughter from the College of Arts & Sciences; and

WHEREAS, Mr. Galant is the CEO and Founder of Tydall Investment Partners, an angel investing and real estate lending and development firm he founded in 2009; and

WHEREAS, Mr. Galant has been an involved volunteer for the University since his graduation. He is a member of the McIntire Foundation Board, has served as a Reunions volunteer, and has hosted and participated in many events for the McIntire School; and

WHEREAS, Mr. Galant is the founder of the Galant Center for Innovation and Entrepreneurship at the McIntire School which encourages, educates, and empowers students to take on roles in the startup community that create positive impact and lasting value in the global marketplace; and

WHEREAS, through funding an emerging scholar professorship, the Galants wish to support growth of the Entrepreneurship minor and to broaden the curricular offerings to prepare students to be not only company founders and startup leaders, but also strategic innovators within existing organizations;

RESOLVED, the Board of Visitors establishes the Galant Bicentennial Professorship at the McIntire School of Commerce; and

RESOLVED FURTHER, the Board of Visitors offers profound thanks to Mark and Cynthia Galant for their very generous contributions of time and resources to the McIntire School of Commerce and the University of Virginia.

WHEREAS, Mr. Richard Tadler and Mrs. Donna Tadler both took degrees from the University: Mr. Tadler from the McIntire School of Commerce, and Mrs. Tadler from the School of Education; and

WHEREAS, Mr. and Mrs. Tadler have been active, engaged alumni and generous donors to the University. Mr. Tadler serves as vice president of the McIntire Foundation Board and co-vice-chair of the Honor The Future Campaign, and Mr. and Mrs. Tadler have hosted events for the McIntire School; and

WHEREAS, the Tadlers wish to support a professorship at the McIntire School of Commerce for faculty teaching and developing related coursework and programming in support of the School’s pan-University minor in Entrepreneurship;

RESOLVED, the Board of Visitors establishes the Richard and Donna Tadler Bicentennial Professorship at the McIntire School of Commerce; and

RESOLVED FURTHER, the Board of Visitors offers profound thanks to Richard and Donna Tadler for their very generous contributions of time and resources to the McIntire School of Commerce and the University of Virginia.

8. ESTABLISHMENT OF THE QUANTITATIVE FOUNDATION BICENTENNIAL PROFESSORSHIP OF EDUCATION

WHEREAS, the Quantitative Foundation is a private nonprofit foundation located in Charlottesville funded by Jaffray and Merrill Woodriff. Mr. Woodriff, a graduate of the McIntire School of Commerce, is a trustee of the Quantitative Foundation. His wife, Merrill, earned a bachelor’s degree from the College of Arts & Sciences and a master’s degree from the School of Education and Human Development, where she serves as a director and secretary on the School of Education and Human Development Foundation board; and

WHEREAS, the Quantitative Foundation’s most recent gift is to the School of Education and Human Development to fund the Quantitative Foundation Bicentennial Professorship of Education. Along with matching funds from the Bicentennial Professors Fund, this gift will enable the School to attract and retain an accomplished scholar in the field of autism and advance ongoing research on autism;

RESOLVED, the Board of Visitors establishes the Quantitative Foundation Bicentennial Professorship of Education at the School of Education and Human Development; and

RESOLVED FURTHER, the Board of Visitors offers profound thanks to Jaffray and Merrill Woodriff and the Quantitative Foundation for this very generous gift to the School of Education and Human Development that will further research and knowledge about autism.

9. NEW DEGREE PROGRAM: DOCTOR OF PHILOSOPHY IN COMPUTATIONAL BIOLOGY IN THE SCHOOL OF MEDICINE

RESOLVED, subject to approval by the State Council of Higher Education for Virginia, the Doctor of Philosophy in Computational Biology is established in the School of Medicine.

10. DEGREE PROGRAM DISCONTINUATION: EDUCATION SPECIALIST IN ADMINISTRATION AND SUPERVISION IN THE SCHOOL OF EDUCATION AND HUMAN DEVELOPMENT

RESOLVED, the Board of Visitors approves the discontinuation of the Ed.S. in Administration and Supervision degree program.

11. FINANCING PLANS FOR THE CHEMISTRY BUILDING FUME EXHAUST RENEWAL, MASSIE ROAD UTILITY EXTENSION, AND TECH TALENT INVESTMENT PROGRAM PHASE I

WHEREAS, the financing plan for the Chemistry Building Fume Exhaust Renewal calls for the use of deferred maintenance funds in the amount of $8.5M; and

WHEREAS, the financing plan for the Massie Road Utility Extension calls for the use of debt in the amount of $6M and the use of operating cash in the amount of $5M; and

WHEREAS, the financing plan for the Tech Talent Investment Program Phase I calls for the use of state general funds in the amount of $3M;

RESOLVED, the Board of Visitors approves the financing plans for the Chemistry Building Fume Exhaust Renewal, Massie Road Utility Extension, and Tech Talent Investment Program Phase I.

WHEREAS, The Rector and Visitors of the University of Virginia, the University of Virginia Foundation, and the UVA School of Architecture Foundation are beneficiaries of the Estate of Priscilla A. Randall and jointly own the property described as residential property located at 27 Pleasant Street in Barrington, Rhode Island; and

WHEREAS, the Board of Visitors finds it to be in the best interest of the University for such property to be sold;

RESOLVED, the Board of Visitors hereby approves the sale of the foregoing property; and

RESOLVED FURTHER, the Executive Vice President and Chief Operating Officer is authorized, on behalf of the University, to approve the sale of the property for such price and in such manner as she may deem reasonable; to approve and execute all agreements, deeds, affidavits, and other documents related to the maintenance, evaluation, and sale of the subject real estate; to incur reasonable and customary expenses; to approve such reasonable and customary expenses, if any, as may have been incurred by the executor or administrator of the estate in connection with the maintenance, evaluation, and sale of the property; and to take such other actions as deemed necessary and appropriate to consummate the sale of the property and distribution of the University’s interest therein; and

RESOLVED FURTHER, that each of the Executive Vice President and Chief Operating Officer and the Associate Vice President for Financial Operations is authorized, on behalf of the University, to approve and execute agency and other agreements with the UVA Foundation and other third parties to perform such actions on the University’s behalf as such officer deems necessary and appropriate in connection with the maintenance, evaluation, and sale of the property; and

RESOLVED FURTHER, all prior acts performed by the Executive Vice President and Chief Operating Officer and other officers and agents of the University, in connection with such maintenance, evaluation, and sale of the property and the administration and distribution of the University’s interest in same, are in all respects approved, ratified, and confirmed.

RESOLVED, the 2021-2022 $1.99B operating budget for the Academic Division, including distributions from the John Lee Pratt Fund, is approved as recommended by the President and the Chief Operating Officer.

14. 2021-2022 OPERATING BUDGET FOR THE UNIVERSITY OF VIRGINIA'S COLLEGE AT WISE

RESOLVED, the 2021-2022 $56.3M operating budget for The University of Virginia’s College at Wise is approved as recommended by the President and the Chief Operating Officer.

15. 2021-2022 OPERATING AND CAPITAL BUDGETS FOR THE UNIVERSITY OF VIRGINIA MEDICAL CENTER

RESOLVED, the 2021-2022 $1.95B operating budget and the $122.6M capital budget for the University of Virginia Medical Center is approved as recommended by the President, the Executive Vice President for Health Affairs, the Chief Operating Officer, and the Health System Board.

16. ISSUANCE OF GENERAL REVENUE PLEDGE BONDS AS PART THE UNIVERSITY'S CAPITAL PROJECT FINANCING PROGRAM

WHEREAS, by the resolution adopted September 15, 2017 (the "Initial Authorizing Resolution"), the Board of Visitors (the "Board") authorized a multi-year capital project financing program (the "Program") that is used by The Rector and Visitors of the University of Virginia (the "University") from time to time to finance or refinance the costs of capital and other projects, including capitalized interest, financing costs, working capital, general corporate purposes and the refunding of prior obligations of the University (collectively, the "Projects"), subject to the limitations and parameters set forth in the Initial Authorizing Resolution and in one or more subsequent resolutions of the Board; and

WHEREAS, under the authority of the Initial Authorizing Resolution, the University entered into a Master Bond Resolution (Multi-Year Capital Program) dated September 28, 2017 (as supplemented and amended, the "Program Resolution"); and

WHEREAS, the bonds issued under the Program Resolution (the "Bonds") are secured by a general revenue pledge of the University and are not in any way a debt of the Commonwealth of Virginia (the "Commonwealth") and do not create or constitute any indebtedness or obligation of the Commonwealth, either legal, moral, or otherwise; and

WHEREAS, the Board desires to authorize additional financing under the Program of up to $400,000,000 of taxable or tax-exempt Bonds that may be issued by the University from time to time to finance or refinance one or more Projects, all subject to the limitations and parameters described (1) below, (2) in the Program Resolution, and (3) in the applicable Series Resolution (as defined below);

RESOLVED, the Board hereby implements the plan of finance described in the recitals hereto by authorizing the issuance, from time to time, of one or more series of Bonds for the financing or refinancing of the Projects (including those Projects financed by the Series 2015B Bonds), and providing for the terms thereof, by adopting one or more resolutions that supplement and amend (as needed) the Program Resolution (each a "Series Resolution"), which shall provide the final terms of the Bonds and such other matters as may be necessary or desirable; and

RESOLVED FURTHER, the President of the University or the Executive Vice President and Chief Operating Officer of the University, in consultation with the Chair of the Board's Finance Committee, is authorized to approve the final terms of each series of Bonds, including, without limitation, their original principal amounts and series, the specific Projects to be financed or refinanced, their maturity dates and amounts, redemption provisions, prices and interest rates, tax status of interest on each series of Bonds, provided that (i) the maximum aggregate principal amount of all Bonds to be issued hereunder shall not exceed $400,000,000; (ii) the Bonds shall be issued at fixed or variable rates with a maximum yield on any fixed rate series, and the maximum initial yield on any variable rate series, not to exceed 6.00% per annum; and (iii) the final maturity of all Bonds shall not exceed 101 years beyond issuance date; and

RESOLVED FURTHER, the President of the University or the Executive Vice President and Chief Operating Officer of the University are each hereby authorized to negotiate, execute, and deliver certain documents related to the Bonds, including a Series Resolution for each series of Bonds; and

RESOLVED FURTHER, all officers of the University are authorized and directed to take all such further actions, including without limitation the designation of underwriters, paying agents, remarketing agents, solicitation agents, trustees, and liquidity providers for the Bonds, and to execute all such instruments, agreements, documents, and certificates as they shall deem necessary or desirable to carry out the terms of the plan of finance presented to this meeting, including without limitation entering into, amending or terminating any liquidity facilities, swap or other interest rate management agreements associated with plan of finance presented to this meeting; and

RESOLVED FURTHER, pursuant to the Section 147(f) of the Internal Revenue Code of 1986, as amended, and applicable regulations thereunder, the University designates the Executive Vice President and Chief Operating Officer of the University as the public hearing

officer to hold any public hearings required in order to ensure the tax-exempt status of interest on all or a portion of the Bonds; and

RESOLVED FURTHER, all acts of all officers of the University which are in conformity with the purposes and intent of this Resolution and in carrying out the plan of finance presented to this meeting are ratified, approved, and affirmed; and

17. CREATION OF THE SAUNDERS FAMILY PROFESSORSHIP IN ENGINEERING RESTRICTED QUASI-ENDOWMENT FUND

WHEREAS, the School of Engineering and Applied Science wishes to create a new restricted quasi-endowment fund for an engineering professorship under the University’s Bicentennial Professorship Fund Matching Program;

RESOLVED, the Board of Visitors authorizes the creation of the Saunders Family Professorship in Engineering Restricted Quasi-Endowment Fund.

18. DIVESTMENT OF THE SCHOOL OF MEDICINE ACADEMIC ADVANCEMENT RESTRICTED QUASI-ENDOWMENT FUND

WHEREAS, the School of Medicine wishes to divest the remaining balance of the Academic Advancement Restricted Quasi-Endowment Fund;

RESOLVED, the Board of Visitors authorizes the divestment of the Academic Advancement Restricted Quasi-Endowment Fund.

WHEREAS, the University has collaborated with Perkins & Will, the Office of the Architect, and the University of Virginia Foundation to develop a long-term strategy for redevelopment of the Ivy Gardens Apartments;

RESOLVED, the Board of Visitors approves the master plan for Ivy Gardens Redevelopment.

WHEREAS, at the September 2020 meeting of the Board of Visitors, the Board formally requested that the University Committee on Names undertake to determine if rededication of the Hume Memorial Wall (also known as the “Whispering Wall”) is appropriate and feasible, or if the memorial should be removed, and make a final recommendation to the Board at a future meeting; and

WHEREAS, in 2021 the University Committee on Names was discontinued and President Ryan charged a newly constituted Naming and Memorials Committee with researching the matter and making a recommendation to the President and Board about the future disposition of the Hume Memorial; and

WHEREAS, the Naming and Memorials Committee completed their work on the future of the Hume Memorial and submitted a memo (Attachment A) to President Ryan in May 2021, concluding that “[I]t is not appropriate to continue to honor Frank Hume. A name adorning a monument on Grounds should be an emblem of our values. Those whom we choose to honor must reflect what we believe in and who we as a community aspire to be. Recognizing that the inscription on the Whispering Wall is commonly read as a “symbol of support for slavery and inequality” (BoV 09 20 Meeting Minutes, p. 11498) the Committee—following an interval of study, consultation, community comment, and reflection—respectfully recommends the wholesale replacement of any and all inscription-bearing blocks in the Whispering Wall with blank blocks of a suitable material, thereby removing the name and memorialization that they have carried;” and

WHEREAS, the Naming and Memorials Committee also noted that Frank Hume did not have a direct tie with the University; rather, his two sons, who were alumni, funded the construction of the Hume Memorial; and

WHEREAS, in recent years the University has removed or renamed a number of symbols of unequal treatment of racial minorities on Grounds, including changing the names of several buildings, removing the Confederate War Memorial plaques from the Rotunda, constructing the Memorial to Enslaved Laborers, and naming a residence hall for a formerly enslaved couple who lived and worked at the University;

RESOLVED, the Board of Visitors requests that the University, following receipt of all necessary approvals, remove the inscription on the Hume Memorial, hereinafter to be known as the “Whispering Wall”, replace the blocks containing the inscription with blocks of a contrasting color to mark the change, and include the story of the Hume Memorial as part of the digital contextualization of statues and memorials on Grounds; and

RESOLVED FURTHER, the design, color, and placement of new material on the Whispering Wall shall be decided collaboratively among the University Architect, the chair of the Buildings and Grounds Committee, and the chair of the Naming and Memorials Committee.

Charged by the Board of Visitors to make a recommendation about the future disposition of the Hume Memorial, the Naming and Memorials Committee respectfully submits the following proposal to President Ryan and the Board.⁵

Mr. Frank Hume: Born in Culpeper (1843), Frank Hume was raised in Alexandria and Washington, DC. As the Civil War was starting, the eighteen-year-old Hume joined the Volunteer Southrons, remaining in the Confederate Army until the conclusion of the war. Hume was subsequently a successful businessman and was twice elected to the Virginia House of Delegates. He also served as a supervisor for the County of Alexandria and as a member of the Washington Board of Trade. Known in northern Virginia for his civic engagement and philanthropy, he donated land to build a school and playground in Arlington. The Hume School was closed in 1958; the building currently houses the Arlington Historical Museum.

Mr. Hume has no discernable connection to the University of Virginia other than the fact that, some twenty years after his death, his alumni sons John Edmund Norris Hume and Howard Hume donated funds to the University to erect a bench with a curved wall and fountain honoring their father. Because more than 75 years have passed since a structure was named for him as a consequence of philanthropy, it is in keeping with established UVA naming protocols to review the status of that naming and how it accords with the University’s values today.

The Hume Memorial: Following approval of the gift by the Board of Visitors, Edmund S. Campbell, UVA Dean of Art and Architecture, created the design for the fountain and bench and in 1937 commissioned the Vermont Marble company to execute it. The structure was originally sited in the north portico of Monroe Hall. In 1988, when Monroe Hall was enlarged, the structure was disassembled and crated for storage. Several years later, the fountain and bench with its whispering wall became the focal point of the Monroe Newcomb Plaza. That site has long been a place of student activity (e.g., “tabling” by student groups and informal socializing).

The Committee’s Recommendation: The Naming and Memorials Committee fully agrees with the Board of Visitors that it is not appropriate to continue to honor Frank Hume. A name adorning a monument on Grounds should be an emblem of our values. Those whom we choose to honor must reflect what we believe in and who we as a community aspire to be. Recognizing that the inscription on the Whispering Wall is commonly read as “a symbol of support for slavery and inequality” (BoV 09 20 Meeting Minutes, p.11498), the Committee—following an interval of study, consultation, community comment, and reflection—respectfully recommends the wholesale replacement of any and all inscription-bearing blocks in the Whispering Wall with blank blocks of a suitable material, thereby removing the name and memorialization that they have carried.⁶

In making this recommendation, however, we in no way wish wholly to erase the history of the University’s original decision and its subsequent tacit ratification over a span of many years. In removing the inscription, we concomitantly affirm our commitment not to silence the history of UVA decision making that led to the creation and perpetuation of a memorial to Frank Hume.

Accordingly, the Committee further recommends that replacement blocks of a contrasting color be used to mark the permanent change that has been made to this structure. (At the request of the Committee, a rendering of this design is to be supplied to the Board through the Office of the University Architect.) The University should not remove the inscription on the Whispering Wall without materially signaling to future generations our need as a community to reassess our understandings and to express our values as we work for a more just and equitable society.⁷ We must continue to interrogate and grapple with our past for the sake of a better future.

In addition, we encourage the nascent Digital Contextualization Working Group to tell the story of what was once the Hume Memorial in such a way that members of the UVA community and visitors to Grounds can learn about and, crucially, learn from the history of this structure and the catena of decisions that that led to the memorialization of Frank Hume at our University over the course of more than eight decades.

It is our hope that the newly configured and repurposed fountain and bench, with its whispering wall stripped of all memorializing inscription, together with the landscaped plaza and surrounding environment on which it stands, will be a place that fosters authentic community, promotes nuanced and complex historical understandings, and occasions debate. It is our hope that this important site will stimulate critical thinking about the value-laden pedagogical power of what and how we remember—and why that matters for our aspirations as a university community committed to fostering the common good.

Our aim, then, in making this recommendation to President Ryan and the Board is neither to erase history nor to change it, but to enliven present and future generations—whose lives, like ours, are invested in our ambitious educational enterprise—to the circumstances under which a significant feature of the built environment on our Grounds was created and named. We seek to inculcate a deeper understanding of why history matters to our University culture and to the values we publicly espouse.

Financials: Estimates from the Office of the University Architect suggest the total cost of removing the blocks above the bench and replacing them in contrasting stone would be approximately $430,000. (The estimate for removal of the monument and requisite modifications to the plaza on which it had stood is a figure between $1,500,000 and $2,000,000.) We are grateful to Alice Raucher and her team for providing this information.

Sequelae: The Virginia Art and Architecture Review Board (AARB) would necessarily review any BoV resolution to alter the Hume Memorial because it stands on property owned by the Commonwealth of Virginia. (We should also note that the proposed modification of the memorial would not require excavation; accordingly, archaeologists would not be consulted.)

Were our recommendation accepted, all future University publications, whether printed or electronic, should henceforth refer to the site as the Whispering Wall. The name “Hume Memorial” should no longer to be used.

21. 2021 MAJOR CAPITAL PLAN FOR THE ACADEMIC DIVISION, UVA HEALTH, AND THE COLLEGE AT WISE

(approved by the Buildings and Grounds Committee on June 4, 2021 – see 2021 Major Capital Plan at Attachment C)

WHEREAS, in accordance with the University’s capital planning process, major capital projects are vetted by the Space Leadership Committee and executive leadership, as well as by appropriate committees of the Board of Visitors, to ensure alignment with institutional priorities; and

WHEREAS, the University proposes adding three projects to the Academic Division’s Major Capital Plan: Democracy Institute, Massie Road Utility Extension, and Tech Talent Investment Program Phase I; and

WHEREAS, at the request of the project sponsors the University proposes removing two projects from the Academic Division’s Major Capital Plan and one project from UVA Health’s Major Capital Plan: Alderman Road Residence Hall – Building 7, Pinn Hall Nobel Laureate Gallery, and Eye Center;

RESOLVED, the 2021 Major Capital Plan for the Academic Division, UVA Health, and the College at Wise is approved.

Dr. Matthew A. Barrick, as Assistant Professor of Dentistry, effective July 1, 2021, for three years, at an annual salary of $100,000.

Ms. Hong-Ru Chen, as Research Assistant Professor of Neuroscience, effective February 15, 2021, for three years, at an annual salary of $75,000.

Mr. Patricio H. Colmegna, as Research Assistant Professor of Psychiatry and Neurobehavioral Sciences, effective March 1, 2021, for three years, at an annual salary of $100,000.

Dr. Ian M. Duensing, as Assistant Professor of Orthopaedic Surgery, effective September 1, 2021, for three years, at an annual salary of $100,000.

José García-Tirado, as Research Assistant Professor of Psychiatry and Neurobehavioral Sciences, effective March 1, 2021, for three years, at an annual salary of $100,000.

Dr. Ariana G. Greenwell, as Assistant Professor of Otolaryngology, Head and Neck Surgery, effective September 1, 2021, for three years, at an annual salary of $100,000.

Dr. Jillian Horning, as Assistant Professor of Emergency Medicine, effective October 1, 2020, for three years, at an annual salary of $100,000.

Ms. Wintre F. Johnson, as Assistant Professor of Education, for the period August 10, 2021 through May 24, 2024, at an academic year salary of $80,000.

Mr. Ian F. Kimbrough, as Research Assistant Professor of Neuroscience, effective June 1, 2021, for three years, at an annual salary of $95,000.

Ms. Traci S. Kutaka, as Research Assistant Professor of Education, effective July 25, 2021, for one year, at an annual salary of $82,000.

Mr. Nicholas E. Larkey, as Assistant Professor of Pathology, effective July 6, 2021, for three years, at an annual salary of $100,000.

Ms. Angela D. Orebaugh, as Assistant Professor of Computer Science, General Faculty, for the period January 25, 2021 through May 24, 2021, at an academic year salary of $100,000.

Mr. Dipan C. Patel, as Research Assistant Professor of Neuroscience, effective June 1, 2021, for three years, at an annual salary of $90,000.

Dr. Philip Roehrs, as Associate Professor of Pediatrics, effective February 12, 2021, for three years, at an annual salary of $100,000.

Mr. Corey A. Rynders, as Research Assistant Professor of Education, effective May 1, 2021, for three years, at an annual salary of $90,000.

Dr. Christopher D. Scott, as Assistant Professor of Surgery, effective March 15, 2021, for three years, at an annual salary of $100,000.

Dr. Yingtang Shi, as Research Assistant Professor of Pharmacology, effective March 25, 2021, for three years, at an annual salary of $70,000.

Ms. Emily A. Snavely, as Assistant Professor of Pathology, effective July 19, 2021, for three years, at an annual salary of $100,000.

Mr. Bhanu P. Tewari, as Research Assistant Professor of Neuroscience, effective June 1, 2021, for three years, at an annual salary of $90,000.

Ms. Crystal Toll, as Assistant Professor of Nursing, General Faculty, for the period January 25, 2021 through May 24, 2024, at an academic year salary of $78,000.

Dr. Sara L. Zadeh, as Assistant Professor of Pathology, effective August 1, 2021, for three years, at an annual salary of $100,000.

Ms. Weiping Zheng, as Assistant Professor of Radiation Oncology, effective April 1, 2021, for one year, at an annual salary of $195,000.

[t] Mr. George S. Allayannis, as Robert F. Bruner Distinguished Professor of Business Administration, effective August 25, 2021, for five years. Mr. Allayannis will continue as Professor of Business Administration, without term.

Ms. Melody C. Barnes, as J. Wilson Newman Professor of Governance at the White Burkett Miller Center of Public Affairs, effective May 25, 2021 through September 24, 2024. Ms. Barnes will continue as Professor of Practice in Public Affairs, through September 24, 2024.

[t] Ms. Daphna Bassok, as Batten Bicentennial Associate Professor of Early Childhood Education, effective August 25, 2021, for five years. Ms. Bassok will continue as Associate Professor of Education, without term.

[t] Mr. Manuel Baucells, as David M. LaCross Associate Professor of Business Administration, effective August 25, 2021, for three years. Mr. Baucells will continue as Associate Professor of Business Administration, without term.

[t] Mr. Alan R. Beckenstein, as Robert D. Landel Distinguished Professor of Business Administration, effective August 25, 2021, for five years. Mr. Beckenstein will continue as Professor of Business Administration, without term.

[t] Mr. Peter R.V. Belmi, as Scott C. Beardsley Associate Professor of Business Administration, effective August 25, 2021, for three years. Mr. Belmi will continue as Associate Professor of Business Administration, without term.

[t] Ms. Ila Berman, as Elwood R. Quesada Professor of Architecture, effective August 25, 2021. Ms. Berman will continue as Professor of Architecture, without term.

[t] Mr. Robert A. Bloodgood, as Harrison Distinguished Teaching Professor of Cell Biology, effective July 25, 2021, for five years. Mr. Bloodgood will continue as Professor of Cell Biology, without term.

[t] Mr. Robert L. Carraway, as Yiorgos Allayannis Distinguished Associate Professor of Business Administration, effective August 25, 2021, for five years. Mr. Carraway will continue as Associate Professor of Business Administration, without term.

[t] Mr. Raul O. Chao, as Oliver Wight Associate Professor of Business Administration, effective August 25, 2021, for three years. Mr. Chao will continue as Associate Professor of Business Administration, without term.

[t] Mr. Luca Cian, as Killgallon Ohio Art Associate Professor of Business Administration, effective August 25, 2021, for three years. Mr. Cian will continue as Associate Professor of Business Administration, without term.

Dr. Anelyssa D'Abreu, as Joan and John Thalheimer Bicentennial Associate Professor of Neurology, for the period July 25, 2021 through August 31, 2023. Dr. D'Abreu will continue as Associate Professor of Neurology, through August 31, 2023.

Ms. Mary C. Gentile, as Richard M. Waitzer Bicentennial Professor of Ethics, effective August 25, 2021, for three years. Ms. Gentile will continue as Professor of Practice in Business Administration, through May 24, 2024.

Ms. Kinda C. Hachem, as Morris Plan Associate Professor of Consumer Credit, for the period August 25, 2021 through May 24, 2023. Ms. Hachem will continue as Associate Professor of Business Administration, through May 24, 2023.

[t] Mr. Justin J. Hopkins, as J. Harvie Wilkinson Jr. Associate Professor of Business Administration, effective August 25, 2021, for three years. Mr. Hopkins will continue as Associate Professor of Business Administration, without term.

[t] Ms. Foteini Kondyli, as Horace W. Goldsmith Distinguished Teaching Associate Professor in the Humanities, effective August 25, 2021, for three years. Ms. Kondyli will continue as Associate Professor of Art, without term.

[t] Mr. Sean Martin, as Donald and Lauren Morel Associate Professor of Business Administration, effective August 25, 2021. Mr. Martin will continue as Associate Professor of Business Administration, without term.

[t] Mr. Micah Mazurek, as Novartis U.S. Foundation Professor of Education, effective August 25, 2021, for five years. Mr. Mazurek will continue as Professor of Education, without term.

[t] Dr. Christopher R. McCartney, as Kenneth R. Crispell Professor of Medicine, effective May 25, 2021, for five years. Dr. McCartney will continue as Professor of Medicine, without term.

[t] Mr. Daniel P. Murphy, as Jung Family Associate Professor of Business Administration, effective August 25, 2021, for three years. Mr. Murphy will continue as Associate Professor of Business Administration, without term.

[t] Mr. Jason A. Papin, as Harrison Distinguished Teaching Professor of Biomedical Engineering, effective July 25, 2021, for five years. Mr. Papin will continue as Professor of Biomedical Engineering, without term.

[t] Mr. Robert C. Pianta, as Batten Bicentennial Professor of Early Childhood Education, effective July 25, 2021, for five years. Mr. Pianta will continue as Professor of Education, without term.

Ms. Elizabeth A. Powell, as Julie Logan Sands Associate Professor of Business Administration, for the period May 8, 2021 through May 24, 2023. Ms. Powell will continue as Associate Professor of Business Administration, General Faculty, through May 24, 2023, and Associate Professor of Nursing, until May 24, 2022.

[t] Ms. Lisa A. Reilly, as Commonwealth Professor of Architectural History, effective August 25, 2021. Ms. Reilly will continue as Professor of Architectural History, without term.

[t] Ms. Emily J. Solari, as Edmund H. Henderson Professor of Education, effective July 25, 2021, for five years. Ms. Solari will continue as Professor of Education, without term.

[t] Mr. Harald W. Sontheimer, as Harrison Distinguished Professor of Neuroscience, effective February 1, 2021. Mr. Sontheimer will continue as Professor of Neuroscience, without term.

[t] Ms. Melissa C. Thomas-Hunt, as John D. Forbes Distinguished Professor of Business Administration, for five years, and as Professor of Business Administration and Professor of Public Policy, without term, effective May 25, 2021, at an annual salary of $333,300.

Ms. June A. West, as Marjorie R. Sands Associate Professor of Business Administration, for the period August 25, 2021 through May 24, 2023. Ms. West will continue as Associate Professor of Business Administration, General Faculty, through May 24, 2023.

Ms. Amanda P. Williford, as Batten Bicentennial Professor of Early Childhood Education, effective July 25, 2021, for three years. Ms. Williford will continue as Research Professor of Education, through July 24, 2024.

[t] Dr. Colleen A. McNamara, from Frances Myers Ball Professor in the Cardiovascular Division of the Department of Internal Medicine, to Beirne B. Carter Professor of Immunology, effective January 1, 2021, for five years. Ms. McNamara will continue as Professor of Medicine, without term.

[t] Dr. James A. Browne, from Alfred R. Shands Jr. Associate Professor of Orthopaedics and Rehabilitation, to Alfred R. Shands Jr. Professor of Orthopaedics and Rehabilitation, effective July 1, 2021. Dr. Browne will continue as Professor of Orthopaedic Surgery, without term.

[t] Dr. Rebecca A. Dillingham, from Harrison Distinguished Teaching Associate Professor of Medicine, to Harrison Distinguished Teaching Professor of Medicine, effective July 1, 2021. Dr. Dillingham will continue as Professor of Medicine, without term, and Professor of Public Health Sciences, for three years, and Professor of Microbiology, Immunology, and Cancer Biology, for three years.

[t] Mr. Gregory B. Fairchild, from Isidore Horween Research Associate Professor of Business Administration, to Isidore Horween Research Professor of Business Administration, effective July 25, 2021. Mr. Fairchild will continue as Professor of Business Administration, without term.

[t] Ms. Morela Hernandez, from Donald and Lauren Morel Associate Professor of Business Administration, to Donald and Lauren Morel Professor of Business Administration, effective August 25, 2021. Ms. Hernandez will continue as Professor of Business Administration, without term, and Professor of Engineering Systems and Environment, for three academic years, and Professor of Psychiatry and Neurobehavioral Sciences, for three academic years.

[t] Dr. Tracey L. Krupski, from Jay Y. Gillenwater Associate Professor of Urology, to Jay Y. Gillenwater Professor of Urology, effective July 1, 2021. Dr. Krupski will continue as Professor of Urology, without term.

[t] Dr. Yun M. Shim, from John L. Guerrant Associate Professor of Internal Medicine, to John L. Guerrant Professor of Internal Medicine, effective July 1, 2021. Dr. Shim will continue as Professor of Medicine, without term, and Professor of Radiology and Medical Imaging, for three years.

[t] Ms. Risa L. Goluboff, Arnold H. Leon Professor of Law, effective July 1, 2021, an annual salary of $568,700.

[t] Mr. Peter C. Brunjes, Commonwealth Professor of Psychology, effective January 9, 2021. Mr. Brunjes had been a faculty member since January 16, 1981.

[t] Mr. Jonathan Z. Cannon, Blaine T. Phillips Distinguished Professor of Environmental Law, effective May 24, 2021. Mr. Cannon had been a faculty member since August 25, 1998.

[t] Dr. Randolph J. Canterbury, Wilford W. Spradlin Professor of Psychiatric Medicine, effective June 30, 2021. Dr. Canterbury has been a faculty member since March 16, 1984.

[t] Dr. Thomas A.E. Platts-Mills, Oscar Swineford Jr. Professor of Medicine, effective February 28, 2021. Dr. Platts-Mills had been a faculty member since October 1, 1982.

Ms. Mariana Teles Santos Golino, from Research Associate Professor of Psychology, to Associate Professor of Psychology, General Faculty, effective August 25, 2021, for three academic years, at an academic year salary of $70,000.

Dr. Vaia T. Abatzis, from Assistant Professor of Anesthesiology, to Associate Professor of Anesthesiology, effective July 1, 2021, for three years.

Mr. Mayuresh M. Abhyankar, from Research Assistant Professor of Medicine, to Research Associate Professor of Medicine, effective July 1, 2021, for three years.

[t] Mr. Herve F. Agaisse, from Associate Professor of Microbiology, Immunology, and Cancer Biology, to Professor of Microbiology, Immunology, and Cancer Biology, effective July 1, 2021.

Mr. Timothy E. Allen, from Associate Professor of Biomedical Engineering, General Faculty, to Professor of Biomedical Engineering, General Faculty, effective August 25, 2021, for three academic years.

Dr. Peter E. Amato, from Assistant Professor of Anesthesiology, to Associate Professor of Anesthesiology, effective July 1, 2021, for three years.

Dr. Christopher J. Arnold, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

[t] Mr. Aditya Bamzai, from Associate Professor of Law, to Professor of Law, effective August 25, 2021.

[t] Mr. Andreas Beling, from Associate Professor of Electrical and Computer Engineering, to Professor of Electrical and Computer Engineering, effective July 25, 2021.

[t] Mr. Peter R.V. Belmi, from Assistant Professor of Business Administration, to Associate Professor of Business Administration, effective August 25, 2021.

[t] Ms. Rosalyn W. Berne, from Associate Professor of Engineering and Society, to Professor of Engineering and Society, effective August 25, 2021.

[t] Mr. Zachary A. Bethune, from Assistant Professor of Economics, to Associate Professor of Economics, effective August 25, 2021.

[t] Ms. Sarah E. Betzer, from Associate Professor of Art, to Professor of Art, effective August 25, 2021.

Ms. Sanchita Bhatnagar, from Assistant Professor of Biochemistry and Molecular Genetics, to Associate Professor of Biochemistry and Molecular Genetics, effective July 1, 2021, for three years. Ms. Bhatnagar will continue as Associate Professor of Neuroscience, for three years.

[t] Dr. Kenneth C. Bilchick, from Associate Professor of Medicine, to Professor of Medicine, effective July 1, 2021.

[t] Mr. Steven M. Bowers, from Assistant Professor of Electrical and Computer Engineering, to Associate Professor of Electrical and Computer Engineering, effective July 25, 2021.

Dr. Sue A. Brown, from Associate Professor of Medicine, to Professor of Medicine, effective July 1, 2021, for three years.

Dr. Jennifer C. Burnsed, from Assistant Professor of Pediatrics, to Associate Professor of Pediatrics, effective July 1, 2021, for three years. Dr. Burnsed will continue as Associate Professor of Neurology, for three years.

Ms. Francesca Calamita, from Assistant Professor of Spanish, Italian, and Portuguese, General Faculty, to Associate Professor of Spanish, Italian, and Portuguese, General Faculty, effective August 25, 2021, for three academic years.

Dr. Adam Carlson, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

[t] Mr. Enrico F. Cesaretti, from Associate Professor of Spanish, Italian, and Portuguese, to Professor of Spanish, Italian, and Portuguese, effective August 25, 2021.

Dr. Sherita N. Chapman, from Assistant Professor of Neurology, to Associate Professor of Neurology, effective July 1, 2021, for three years.

[t] Mr. Jack W. Chen, from Associate Professor of East Asian Languages, Literatures, and Cultures, to Professor of East Asian Languages, Literatures, and Cultures, effective August 25, 2021.

Ms. Shu-Chen Chen, from Assistant Professor of East Asian Languages, Literatures and Cultures, General Faculty, to Associate Professor of East Asian Languages, Literatures and Cultures, General Faculty, effective August 25, 2021, for three academic years.

[t] Mr. Gia-Wei Chern, from Assistant Professor of Physics, to Associate Professor of Physics, effective August 25, 2021.

Ms. Marcia D. Childress, from Associate Professor of Medical Education, to Professor of Medical Education, for the period July 1, 2021 through July 24, 2021.

Mr. Tushar Chopra, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

[t] Mr. Luca Cian, from Assistant Professor of Business Administration, to Associate Professor of Business Administration, effective August 25, 2021.

Mr. Mete Civelek, from Assistant Professor of Biomedical Engineering, to Associate Professor of Biomedical Engineering, effective July 1, 2021, for three years. Mr. Civelek will continue as Associate Professor of Biochemistry and Molecular Genetics, for three years.

[t] Ms. Alison K. Criss, from Associate Professor of Microbiology, Immunology and Cancer Biology, to Professor of Microbiology, Immunology and Cancer Biology, effective July 1, 2021.

[t] Dr. Stephen H. Culp, from Associate Professor of Urology, with term, to Associate Professor of Urology, without term, effective July 1, 2021.

Mr. David N. Dalton, from Assistant Professor of Drama, General Faculty, to Associate Professor of Drama, General Faculty, effective August 25, 2021, for three academic years.

[t] Dr. Andrew E. Darby, from Associate Professor of Medicine, with term, to Associate Professor of Medicine, without term, effective July 1, 2021.

[t] Dr. Dylan N. Deal, from Associate Professor of Orthopaedic Surgery, to Professor of Orthopaedic Surgery, effective July 1, 2021. Dr. Deal will continue as Professor of Plastic Surgery, for three years.

[t] Mr. Haibo Dong, from Associate Professor of Mechanical and Aerospace Engineering, to Professor of Mechanical and Aerospace Engineering, effective August 25, 2021.

Mr. Devin J. Donovan, from Assistant Professor of English, General Faculty, to Associate Professor of English, General Faculty, effective August 25, 2021, for three academic years.

Dr. Brett J. Elmore, from Assistant Professor of Anesthesiology, to Associate Professor of Anesthesiology, effective July 1, 2021, for three years.

Mr. Thomas J. Eluvathingal Muttikkal, from Assistant Professor of Radiology and Medical Imaging, to Associate Professor of Radiology and Medical Imaging, effective July 1, 2021, for three years.

Mr. Mark R. Floryan, from Assistant Professor of Computer Science, General Faculty, to Associate Professor of Computer Science, General Faculty, effective August 25, 2021, for three years.

Mr. Joe Fore, from Associate Professor of Law, General Faculty, to Professor of Law, General Faculty, effective July 25, 2021, for three years.

Dr. Laahn H. Foster, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

Dr. Deborah K. Froh, from Associate Professor of Pediatrics, to Professor of Pediatrics, effective July 1, 2021, for three years.

Dr. Jeffrey W. Gander, from Assistant Professor of Surgery, to Associate Professor of Surgery, effective July 1, 2021, for three years.

Dr. Andrea S. Garrod, from Assistant Professor of Pediatrics, to Associate Professor of Pediatrics, effective July 1, 2021, for three years.

Mr. Zvi Gilboa, from Assistant Professor of Middle Eastern & South Asian Languages & Cultures, General Faculty, to Associate Professor of Middle Eastern & South Asian Languages & Cultures, General Faculty, effective August 25, 2021, for three academic years.

Ms. Jennifer L. Givens, from Associate Professor of Law, General Faculty, to Professor of Law, General Faculty, effective July 25, 2021, for three years.

[t] Dr. Traci L. Hedrick, from Associate Professor of Surgery, with term, to Associate Professor of Surgery, without term, effective July 1, 2021.

Dr. Kristen C. Heinan, from Assistant Professor of Neurology, to Associate Professor of Neurology, effective July 1, 2021, for three years.

[t] Dr. Scott Heysell, from Associate Professor of Medicine, with term, to Associate Professor of Medicine, without term, effective July 1, 2021.

Dr. Amber N. Inofuentes, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

Dr. Valentina Intagliata, from Assistant Professor of Pediatrics, to Associate Professor of Pediatrics, effective July 1, 2021, for three years.

[t] Mr. Vikram K. Jaswal, from Associate Professor of Psychology, to Professor of Psychology, effective August 25, 2021.

Dr. Jeffrey Jenkins, from Associate Professor of Physical Medicine and Rehabilitation, to Professor of Physical Medicine and Rehabilitation, effective July 1, 2021, for three years.

Dr. Kristina G. Johnson, from Assistant Professor of Family Medicine, to Associate Professor of Family Medicine, effective July 1, 2021, for three years.

[t] Mr. Steven L. Johnson, from Associate Professor of Commerce, with term, to Associate Professor of Commerce, without term, effective August 25, 2021.

[t] Ms. Mona Kasra, from Assistant Professor of Drama, to Associate Professor of Drama, effective August 25, 2021.

Mr. Volker Kiessling, from Assistant Professor of Research in Molecular Physiology and Biological Physics, to Associate Professor of Research in Molecular Physiology and Biological Physics, effective July 1, 2021, for three years.

Dr. Amanda M. Kleiman, from Assistant Professor of Anesthesiology, to Associate Professor of Anesthesiology, effective July 1, 2021, for three years.

[t] Mr. Leidy Klotz, from Associate Professor of Engineering Systems and Environment, to Professor of Engineering Systems and Environment, effective July 25, 2021. Mr. Klotz will continue as Professor of Architecture, for three years.

[t] Mr. Anton Korinek, from Associate Professor of Economics, to Professor of Economics, effective August 25, 2021.

[t] Ms. Gabrielle K. Kruks-Wisner, from Assistant Professor of Politics, to Associate Professor of Politics, effective August 25, 2021. Ms. Kruks-Wisner will continue as Associate Professor of Global Studies, for three years.

[t] Ms. Kisha Lashley, from Assistant Professor of Commerce, to Associate Professor of Commerce, effective August 25, 2021.

[t] Ms. Virginia T. LeBaron, from Assistant Professor of Nursing, to Associate Professor of Nursing, effective August 25, 2021. Ms. LeBaron will continue as Associate Professor of Medicine, for three years.

Dr. Simon J. Lehtinen, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

[t] Mr. Hui Li, from Associate Professor of Pathology, to Professor of Pathology, effective July 1, 2021. Mr. Li will continue as Professor of Biochemistry and Molecular Genetics, for three years.

[t] Ms. Jingjing Li, from Assistant Professor of Commerce, to Associate Professor of Commerce, effective August 25, 2021.

[t] Dr. Xudong Li, from Associate Professor of Orthopaedic Surgery, with term, to Associate Professor of Orthopaedic Surgery, without term, effective July 1, 2021. Dr. Li will continue as Associate Professor of Biomedical Engineering, for three years.

Ms. Jennifer M. Lobo, from Assistant Professor of Public Health Sciences, to Associate Professor of Public Health Sciences, effective July 1, 2021, for three years.

Ms. Alicia López-Operé, from Assistant Professor of Spanish, Italian, and Portuguese, General Faculty, to Associate Professor of Spanish, Italian, and Portugese, General Faculty, effective August 25, 2021, for three academic years.

Ms. Esther Lorenz, from Assistant Professor of Architecture, General Faculty, to Associate Professor of Architecture, General Faculty, effective August 25, 2021, for three academic years.

[t] Mr. John R. Lukens, from Associate Professor of Neuroscience, to Professor of Neuroscience, effective July 1, 2021.

[t] Dr. Rohit Malhotra, from Associate Professor of Medicine, with term, to Associate Professor of Medicine, without term, effective July 1, 2021.

Mr. Numaan F. Malik, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

Dr. Howard C. Malpass, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

[t] Dr. Linda W. Martin, from Associate Professor of Surgery, with term, to Associate Professor of Surgery, without term, effective July 1, 2021.

[t] Mr. Sean Martin, from Associate Professor of Business Administration, with term, to Associate Professor of Business Administration, without term, effective August 25, 2021.

Ms. Ines M. Martin Robles, from Assistant Professor of Architecture, General Faculty, to Associate Professor of Architecture, General Faculty, effective August 25, 2021, for three academic years.

Ms. Gretchen F. Martinet, from Assistant Professor of Statistics, General Faculty, to Associate Professor of Statistics, General Faculty, effective August 25, 2021, for three academic years.

[t] Dr. Pamela Mason, from Associate Professor of Medicine, to Professor of Medicine, effective July 1, 2021.

Ms. Julia S. May, from Assistant Professor of Interdisciplinary Studies, General Faculty, to Associate Professor of Interdisciplinary Studies, General Faculty, effective July 25, 2021, for three years.

[t] Mr. Micah Mazurek, from Associate Professor of Education, to Professor of Education, effective August 25, 2021.

Dr. Emily C. McGowan, from Assistant Professor of Medicine, to Associate Professor of Medicine, effective July 1, 2021, for three years.

[t] Mr. Chad D. Meliza, from Assistant Professor of Psychology, to Associate Professor of Psychology, effective July 25, 2021.

[t] Ms. Nicole V. Montgomery, from Associate Professor of Commerce, to Professor of Commerce, effective August 25, 2021.

[t] Dr. Sean R. Moore, from Associate Professor of Pediatrics, to Professor of Pediatrics, effective July 1, 2021.

Dr. Sugoto Mukherjee, from Associate Professor of Radiology and Medical Imaging, to Professor of Radiology and Medical Imaging, effective July 1, 2021, for three years. Dr. Mukherjee will continue as Professor of Otolaryngology, Head and Neck Surgery, for three years.

Mr. Josyf C. Mychaleckyj, from Associate Professor of Public Health Sciences, to Professor of Public Health Sciences, effective July 1, 2021, for three years.

Mr. Noah Myung, from Assistant Professor of Public Policy, General Faculty, to Associate Professor of Public Policy, General Faculty, effective August 25, 2021, for three academic years.

[t] Mr. Christopher C. Neu, from Associate Professor of Physics, to Professor of Physics, effective August 25, 2021.

[t] Dr. Patrick G. Northup, from Associate Professor of Medicine, to Professor of Medicine, effective July 1, 2021.

[t] Mr. Ricardo Padron, from Associate Professor of Spanish, Italian, and Portuguese, to Professor of Spanish, Italian, and Portuguese, effective August 25, 2021.

[t] Mr. Luis G. Pancorbo Crespo, from Assistant Professor of Architecture, to Associate Professor of Architecture, effective August 25, 2021.

Mr. Andrew S. Pennock, from Assistant Professor of Public Policy, General Faculty, to Associate Professor of Public Policy, General Faculty, effective August 25, 2021, for three academic years.

Ms. Marcia L. Pentz-Harris, from Assistant Professor of Commerce, General Faculty, to Associate Professor of Commerce, General Faculty, effective August 25, 2021, for three academic years.

[t] Ms. Amanda Phillips, from Assistant Professor of Art, to Associate Professor of Art, effective August 25, 2021.

[t] Mr. Simone Polillo, from Associate Professor of Sociology, to Professor of Sociology, effective August 25, 2021.

[t] Ms. Rebecca R. Pompano, from Assistant Professor of Chemistry, to Associate Professor of Chemistry, effective July 25, 2021. Ms. Pompano will continue as Associate Professor of Biomedical Engineering, for three years.

[t] Ms. Rachel A. Potter, from Assistant Professor of Politics, to Associate Professor of Politics, effective August 25, 2021.

Dr. David E. Rapp, from Associate Professor of Urology, to Professor of Urology, effective July 1, 2021, for three years.

[t] Mr. Jacob E. Resch, from Assistant Professor of Education, to Associate Professor of Education, effective July 25, 2021.

[t] Ms. Christa N. Robbins, from Assistant Professor of Art, to Associate Professor of Art, effective August 25, 2021.

Dr. Mark E. Roeser, from Assistant Professor of Surgery, to Associate Professor of Surgery, effective July 1, 2021, for three years.

[t] Ms. Amanda P. Russell, from Associate Professor of Commerce, to Professor of Commerce, effective August 25, 2021.

Mr. Shawn D. Russell, from Assistant Professor of Orthopaedic Surgery, to Associate Professor of Orthopaedic Surgery, effective July 1, 2021, for three years. Mr. Russell will continue as Associate Professor of Biomedical Engineering, for three years, and Associate Professor of Mechanical and Aerospace Engineering, for three years.

Ms. Karen M. Schmidt, from Associate Professor of Psychology, General Faculty, to Professor of Psychology, General Faculty, effective August 25, 2021, for three academic years.

[t] Dr. Anneke T. Schroen, from Associate Professor of Surgery, to Professor of Surgery, effective July 1, 2021. Dr. Schroen will continue as Professor of Public Health Sciences, for three years.

Ms. Sandra S. Seidel, from Associate Professor, General Faculty, to Professor, General Faculty, effective July 25, 2021, for three years.

Ms. Laura Shaffer, from Associate Professor of Pediatrics, to Professor of Pediatrics, effective July 1, 2021, for three years.

[t] Dr. Binit B. Shah, from Associate Professor of Neurology, with term, to Associate Professor of Neurology, without term, effective July 1, 2021.

[t] Dr. Yevgeniy Shildkrot, from Associate Professor of Ophthalmology, with term, to Associate Professor of Ophthalmology, without term, effective July 1, 2021.

[t] Mr. Jay P. Shimshack, from Associate Professor of Public Policy, to Professor of Public Policy, effective August 25, 2021.

[t] Mr. Jung-Bum Shin, from Associate Professor of Neuroscience, with term, to Associate Professor of Neuroscience, without term, effective July 1, 2021. Mr. Shin will continue as Associate Professor of Cell Biology, for three years, and Associate Professor of Biochemistry and Molecular Genetics, for three years.

[t] Mr. Mark A. Sicoli, from Assistant Professor of Anthropology, to Associate Professor of Anthropology, effective August 25, 2021.

Mr. Jogender Singh, from Assistant Professor of Biochemistry and Molecular Genetics, to Associate Professor of Biochemistry and Molecular Genetics, effective July 1, 2021, for three years.

Mr. Michael P. Slon, from Associate Professor of Music, General Faculty, to Professor of Music, General Faculty, effective August 25, 2021, for three academic years.

[t] Dr. Philip W. Smith, from Associate Professor of Surgery, with term, to Associate Professor of Surgery, without term, effective July 1, 2021.

[t] Mr. Swapnil K. Sonkusare, from Assistant Professor of Molecular Physiology & Biological Physics, to Associate Professor of Molecular Physiology & Biological Physics, effective July 1, 2021. Mr. Sonkusare will continue as Associate Professor of Pharmacology, for three years.

Dr. Carrie E. Sopata, from Assistant Professor of Obstetrics and Gynecology, to Associate Professor of Obstetrics and Gynecology, effective July 1, 2021, for three years.

[t] Ms. Rebecca L. Stangl, from Associate Professor of Philosophy, to Professor of Philosophy, effective August 25, 2021.

[t] Dr. Siobhan M. Statuta, from Associate Professor of Family Medicine, with term, to Associate Professor of Family Medicine, without term, effective July 1, 2021. Dr. Statuta will continue as Associate Professor of Physical Medicine and Rehabilitation, for three years.

[t] Mr. Andrew M. Stauffer, from Associate Professor of English, to Professor of English, effective August 25, 2021.

Dr. Ina Stephens, from Associate Professor of Pediatrics, to Professor of Pediatrics, effective July 1, 2021, for three years.

Dr. Jonathan R. Swanson, from Associate Professor of Pediatrics, to Professor of Pediatrics, effective July 1, 2021, for three years.

Ms. Sana Syed, from Assistant Professor of Pediatrics, to Associate Professor of Pediatrics, effective July 1, 2021, for three years.

[t] Dr. Angela Taylor, from Associate Professor of Medicine, to Professor of Medicine, effective July 1, 2021.

Dr. Danny J. Theodore, from Assistant Professor of Anesthesiology, to Associate Professor of Anesthesiology, effective July 1, 2021, for three years.

Dr. Robert Thiele, from Associate Professor of Anesthesiology, with term, to Associate Professor of Anesthesiology, without term, effective July 1, 2021. Dr. Thiele will continue as Associate Professor of Biomedical Engineering, for three years.

[t] Ms. Xin Tong, from Assistant Professor of Psychology, to Associate Professor of Psychology, effective August 25, 2021.

Mr. Luther A. Tychonievich, from Assistant Professor of Computer Science, General Faculty, to Associate Professor of Computer Science, General Faculty, effective August 25, 2021, for three academic years.

[t] Ms. Rupa S. Valdez, from Associate Professor of Public Health Sciences, with term, to Associate Professor of Public Health Sciences, without term, effective August 25, 2021.

[t] Mr. John D. Van Horn, from Professor of Psychology, with term, to Professor of Psychology, without term, effective August 25, 2021. Mr. Van Horn will continue as Professor of Data Science, for three academic years.

Ms. Luzita Vela, from Assistant Professor of Education, General Faculty, to Associate Professor of Education, General Faculty, effective July 25, 2021, for three years.

[t] Mr. Nolan A. Wages, from Associate Professor of Public Health Sciences, with term, to Associate Professor of Public Health Sciences, without term, effective July 1, 2021.

Dr. Brian C. Werner, from Assistant Professor of Orthopaedic Surgery, to Associate Professor of Orthopaedic Surgery, effective July 1, 2021, for three years.

Ms. Krishni Wijesooriya, from Associate Professor of Radiation Oncology, to Professor of Radiation Oncology, effective July 1, 2021, for three years. Ms. Wijesooriya will continue as Professor of Physics, for three years.

[t] Mr. Richard J. Will, from Associate Professor of Music, to Professor of Music, effective August 25, 2021.

Ms. Amanda P. Williford, from Research Associate Professor of Education, to Research Professor of Education, effective July 25, 2021, for three years.

Mr. Wenhao Xu, from Associate Professor of Research in Microbiology, Immunology, and Cancer Biology to Professor of Research in Microbiology, Immunology, and Cancer Biology, effective July 1, 2021, for three years.

[t] Ms. Guofen Yan, from Associate Professor of Public Health Sciences, to Professor of Public Health Sciences, effective July 1, 2021.

[t] Dr. Zequan Yang, from Associate Professor of Surgery, with term, to Associate Professor of Surgery, without term, effective July 1, 2021.

[t] Ms. Mona Zebarjadi, from Assistant Professor of Electrical and Computer Engineering, to Associate Professor of Electrical and Computer Engineering, effective August 25, 2021. Ms. Zebarjadi will continue as Associate Professor of Materials Science and Engineering, for three academic years.

[t] Ms. Cong Zhang, from Associate Professor of History, to Professor of History, effective August 25, 2021.

4. SPECIAL SALARY ACTIONS

[t] Ms. Julia J. Cohen, Associate Professor of Education, effective February 25, 2021, an annual salary of $160,000.

[t] Mr. Hui Li, Associate Professor of Pathology, effective February 25, 2021, an annual salary of $225,000.

Dr. Weibin Shi, Professor of Radiology and Medical Imaging, effective February 25, 2021, an annual salary of $150,800.

Mr. David H. Eddy Spicer, Professor of Education, General Faculty, effective January 25, 2021, an annual salary of $134,900.

Mr. Mark B. Williams, Professor of Radiology and Medical Imaging, effective February 25, 2021, an annual salary of $150,900.

5. RESIGNATIONS

[t] Mr. Peter A. Beling, Professor of Systems and Information Engineering, effective June 24, 2021.

Mr. Manley T.F. Huang, Assistant Professor of Medicine, effective April 30, 2021.

Dr. Amy A. Kakkanatt, Assistant Professor of Pediatrics, effective July 23, 2021.

Mr. Nagaraj Kerur, Assistant Professor of Ophthalmology, effective March 31, 2021.

Mr. Binyong Liang, Assistant Professor of Research in Molecular Physiology & Biological Physics, effective March 12, 2021.

Dr. Jessica A. Lundgren, Assistant Professor of Medicine, effective June 30, 2021.

[t] Dr. Carlene A Muto, Associate Professor of Medicine, effective June 30, 2021.

Mr. Scott Schwartz, Assistant Professor of Data Science, General Faculty, effective May 23, 2021.

Ms. Ozlem Yildiz, Assistant Professor of Business Administration, effective February 19, 2021.

6. RETIREMENTS

Dr. David C. Abdullah, Associate Professor of Radiology, effective January 31, 2021. Dr. Abdullah had been a faculty member since September 2, 2002.

Mr. Lucien L. Bass III, Professor of Practice in Commerce, effective December 31, 2020. Mr. Bass had been a faculty member since August 25, 1999.

Mr. Paul S. Bourdon, Professor of Mathematics, General Faculty, effective May 24, 2021. Mr. Bourdon had been a faculty member since August 19, 2013.

Ms. Marcia D. Childress, Professor of Medical Education, effective July 24, 2021. Ms. Childress has been a faculty member since August 11, 1975.

Dr. Stephen V. Early, Associate Professor of Otolaryngology, Head and Neck Surgery, effective June 30, 2021. Dr. Early has been a faculty member since August 25, 2001.

Ms. Anita T. Heisterman, Assistant Professor of Nursing, General Faculty, effective May 31, 2021. Ms. Heisterman had been a faculty member since October 22, 1995.

[t] Mr. Joel W. Hockensmith, Associate Professor of Biochemistry and Molecular Genetics, effective July 24, 2021. Mr. Hockensmith has been a faculty member since July 1, 1986.

[t] Dr. John Stephen Huff, Professor of Emergency Medicine, effective June 30, 2021. Dr. Huff has been a faculty member since June 16, 1995.

[t] Mr. Charles Menefee, Associate Professor of Architecture, effective May 24 2021. Mr. Menefee had been a faculty member since September 1, 1991.

Mr. Joel E. Rubin, Associate Professor of Music, General Faculty, effective May 24, 2021. Mr. Rubin had been a faculty member since August 25, 2006.

Mr. Frederick L. Smyth, Assistant Professor of Psychology, General Faculty, effective May 24, 2021. Mr. Smyth had been a faculty member since May 19, 1999.

[t] Mr. Christopher Tilghman, Professor of Creative Writing, effective May 24, 2021. Mr. Tilghman had been a faculty member since January 9, 2001.

Mr. Yuri Urbanovich, Associate Professor of Interdisciplinary Studies, General Faculty, effective May 24, 2021. Mr. Urbanovich had been a faculty member since September 1, 1994.

Ms. Janet I. Warren, Professor of Psychiatry and Neurobehavioral Sciences, effective June 24, 2021. Ms. Warren had been a faculty member since April 23, 1981.

[t] Mr. Melvin N. Wilson, Professor of Psychology, effective May 24, 2021. Mr. Wilson had been a faculty member since September 1, 1979.

Mr. William R. Wilkerson, Associate Professor of Commerce, General Faculty, effective May 24, 2021. Mr. Wilkerson had been a faculty member since July 9, 1975.

RESOLVED, the retirement of Mr. Ira W. Herbst, Professor of Mathematics, effective August 24, 2021 as shown in the Board of Visitors minutes dated March 5, 2021, is corrected to read as follows:

[t] Mr. Ira W. Herbst, Professor of Mathematics, effective May 24, 2021. Mr. Herbst has been a faculty member since September 1, 1977.

8. ELECTION OF MS. ROBYN HADLEY AS VICE PRESIDENT AND CHIEF STUDENT AFFAIRS OFFICER

RESOLVED, Ms. Robyn Hadley is elected Vice President and Chief Student Affairs Officer, for five years, effective June 1, 2021, at an annual salary of $310,000.

9. ELECTION OF CARLA G. WILLIAMS AS VICE PRESIDENT AND DIRECTOR OF INTERCOLLEGIATE ATHLETICS PROGRAMS

RESOLVED, Ms. Carla G. Williams, is elected Vice President and Director of Intercollegiate Athletics Programs, effective June 1, 2021 through May 31, 2025.

RESOLVED, Ms. Virginia H. Evans is re-elected Vice President and Chief Information Officer, effective July 6, 2021 through July 5, 2026.

Ms. Jennifer L. West, as Dean of the School of Engineering and Applied Science, for five years, effective July 1, 2021.

Mr. Malo A. Hutson, as Dean of the School of Architecture, for five years, effective July 1, 2021.

12. ELECTION OF PROFESSORS EMERITI

Mr. Lucien L. Bass III, as Professor of Practice Emeritus in Commerce, effective January 1, 2021.

[t] Mr. Peter C. Brunjes, as Commonwealth Professor Emeritus of Psychology, effective January 10, 2021.

[t] Mr. Jonathan Z. Cannon, as Blaine T. Phillips Distinguished Professor Emeritus of Environmental Law, effective May 25, 2021.

[t] Dr. Randolph J. Canterbury, as Wilford W. Spradlin Professor Emeritus of Psychiatric Medicine, effective July 1, 2021.

Ms. Marcia D. Childress, as Professor Emerita of Medical Education, effective July 25, 2021.

[t] Dr. John Stephen Huff, as Professor Emeritus of Emergency Medicine, effective July 1, 2021.

[t] Mr. Robert S. Kemp, as Raymon W. Breeden Sr. Research Professor of Commerce Emeritus of Commerce, effective May 25, 2021.

[t] Dr. Thomas A.E. Platts-Mills, as Oscar Swineford Jr. Professor Emeritus of Medicine, effective March 1, 2021.

[t] Mr. Christopher Tilghman, as Professor Emeritus of Creative Writing, effective May 25, 2021.

Ms. Janet I. Warren, as Professor Emerita of Psychiatry and Neurobehavioral Sciences, effective June 25, 2021.

[t] Mr. Melvin N. Wilson, as Professor Emeritus of Psychology, effective May 25, 2021.

RESOLVED, the election of Mr. Ira W. Herbst as Professor Emeritus of Mathematics, effective August 25, 2021 as shown in the Board of Visitors minutes dated March 5, 2021, is corrected to read as follows:

[t] Mr. Ira W. Herbst, Professor Emeritus of Mathematics, effective May 25, 2021.

14. ELECTION OF ASSOCIATE PROFESSORS EMERITI

Dr. Stephen V. Early, as Associate Professor Emeritus of Otolaryngology, Head and Neck Surgery, effective July 1, 2021.

[t] Mr. Joel W. Hockensmith, as Associate Professor Emeritus of Biochemistry and Molecular Genetics, effective July 25, 2021.

[t] Mr. Charles Menefee, as Associate Professor Emeritus of Architecture, effective May 25, 2021.

Mr. Yuri Urbanovich, as Associate Professor Emeritus of Interdisciplinary Studies, General Faculty, effective May 25, 2021.

Mr. William R. Wilkerson, as Associate Professor Emeritus of Commerce, General Faculty, effective May 25, 2021.

Mr. Marvin L. Colker, Professor Emeritus of Classics, died May 26, 2020. Mr. Colker had been a member of the faculty from February 1, 1953 until retiring effective May 24, 1998.

Dr. William T. Ross Jr., Professor Emeritus of Clinical Anesthesiology, died February 5, 2021. Dr. Ross had been a faculty member from July 1, 1971, until retiring November 4, 2005.

Mr. Michael J. Weber, Marion McNulty Weaver and Malvin C. Weaver Professor Emeritus of Oncology, died February 22, 2021. Mr. Weber had been a member of the faculty from July 1, 1983, until retiring July 1, 2017.

Ms. Nancy J. Smith Haugen, as Kathleen Miller Strunk Professor of Nursing, The University of Virginia's College at Wise, and Professor of Nursing, The University of Virginia’s College at Wise, effective March 15, 2021, for five years, at an annual salary of $145,000.

[t] Mr. Benjamin Mays, Associate Professor of Theatre, The University of Virginia's College at Wise, effective December 25, 2020, an annual salary of $72,000.

19. RETIREMENTS

[t] Mr. Robin P. Benke, Associate Professor of Library Sciences, The University of Virginia's College at Wise, effective May 24, 2021. Mr. Benke had been a faculty member since November 1, 1978.

[t] Ms. Debra L. Carter, Associate Professor of Nursing, The University of Virginia's College at Wise, effective May 24, 2021. Ms. Carter had been a faculty member since August 25, 1988.

[t] Mr. James E. Horton, Professor of Psychology, The University of Virginia's College at Wise, effective May 24, 2021. Mr. Horton had been a faculty member since September 1, 1995.

[t] Mr. Bryan H. Hoyt, Professor of Psychology, The University of Virginia's College at Wise, effective May 24, 2021. Mr. Hoyt had been a faculty member since August 25, 2002.

[t] Mr. Robert S. Kemp, Raymon W. Breeden Sr. Research Professor of Commerce, effective May 24, 2021. Mr. Kemp had been a faculty member since September 1, 1980.

[t] Mr. Michael E. Odonnell, Assistant Professor of French, The University of Virginia's College at Wise, effective May 24, 2021. Mr. Odonnell had been a faculty member since September 1, 1968.

[t] Ms. Sandra C. Richardson, Professor of Education, The University of Virginia's College at Wise, effective May 24, 2021. Ms. Richardson had been a faculty member since September 1, 1992.

20. ELECTION OF PROFESSORS EMERITI

[t] Mr. James E. Horton, as Professor Emeritus of Psychology, The University of Virginia's College at Wise, effective May 25, 2021.

[t] Mr. Bryan H. Hoyt, as Professor Emeritus of Psychology, The University of Virginia's College at Wise, effective May 25, 2021.

[t] Ms. Sandra C. Richardson, Professor Emerita of Education, The University of Virginia's College at Wise, effective May 25, 2021.

[t] Mr. Robin P. Benke, as Associate Professor Emeritus of Library Sciences, The University of Virginia's College at Wise, effective May 25, 2021.

[t] Ms. Debra L. Carter, as Associate Professor Emerita of Nursing, The University of Virginia's College at Wise, effective May 25, 2021.

[t] Mr. Michael E. O’Donnell, Associate Professor Emeritus of French, The University of Virginia's College at Wise, effective May 25, 2021.

These minutes have been posted to the University of Virginia’s Board of Visitors website.

RESOLVED, the Health System Board supports the Medical Center's continued designation as a Level I Trauma Center by the Commonwealth and the American College of Surgeons; and

RESOLVED FURTHER, the Medical Center commits to maintain the high standards needed to provide optimal care to all trauma patients.

COMBINING THE CLINICAL STAFF MEMBERSHIP OF THE UVA MEDICAL CENTER AND THE UVA TRANSITIONAL CARE HOSPITAL INTO A JOINT, INTEGRATED MEDICAL STAFF

RESOLVED, the University of Virginia Health System Board approves the combination of the Medical Center and the Transitional Care Hospital into one unified, integrated UVA Clinical Staff.

The following resolutions were adopted in a Board committee and do not require approval by the full Board; they are enumerated below as a matter of record.

RESOLVED, recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:

Hatter, Dennis, M.D., Physician in the Department of Family Medicine; Attending Staff Status; Period of Appointment: April 13, 2021, through April 12, 2022; Privileged in Family Medicine.

Reyes, Joshua, M.D., Pediatrician in the Department of Pediatrics; Instructor Staff Status; Period of Appointment: May 1, 2021, through April 30, 2022; Privileged in Pediatrics.

Wilkowski, Michael, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Appointment: April 21, 2021, through April 21, 2022; Privileged in Medicine.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for reappointment to the Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:

Agarwal, Avinash, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Surgery.

Angle, John, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Radiology and Medical Imaging.

Bender, Scott, Ph.D., Psychologist in the Department of Psychiatry and Neurobehavioral Sciences; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Clinical Psychology.

Brochmeier, Stephen, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Orthopedic Surgery.

Cathro, Helen, MBCh.B., Pathologist in the Department of Pathology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Pathology.

Cantrell, Leigh, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Obstetrics and Gynecology.

Clifford, Kevin, D.D.S., Dentist in the Department of Dentistry; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Dentistry.

Dalkin, Alan, M.D., Endocrinologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Daniero, James, M.D., Otolaryngologist in the Department of Otolaryngology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Otolaryngology.

Dreicer, Robert, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Fairchild, Karen, M.D., Neonatologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Pediatrics.

Flannagan, Molly, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: June 1, 2021, through December 30, 2022; Privileged in Surgery.

Frick, Keith, M.D., Rheumatologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 4, 2021, through June 3, 2023; Privileged in Medicine.

Gilmore, Taylor, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Obstetrics and Gynecology.

Hanson, Neil, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: June 1, 2021, through August 30, 2022; Privileged in Anesthesiology.

Hoke, George, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Kaur, Varinder, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Keng, Michael, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Ling, David, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Lundgren, Jessica, M.D., Endocrinologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

McNeil, John, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Anesthesiology.

Marcupulos, Bernice, Ph.D., Psychologist in the Department of Psychiatry and Neurobehavioral Sciences; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Neuropsychology.

Martin, Benjamin, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Mazimba, Sula, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Mehta, Amar, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: May 18, 2021, through March 30, 2022; Privileged in Radiology and Medical Imaging.

Mendoza, Joanne, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Pediatrics.

Meyer, Jessica, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Pediatrics.

Millard, Trish, M.D., Hematologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Moore, Sean, M.D., Pediatric Gastroenterologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Pediatrics.

Nishio Lucar, Angie, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Purow, Benjamin, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Neurology.

Shaffer, Kelly, Ph.D., Psychologist in the Department of Psychiatry and Neurobehavioral Sciences; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Clinical Psychology.

Sharma, Aditya, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Smith, Clyde, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Pediatrics.

Sneed, Benjamin, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Snyder, Bryan, D.PM, Podiatrist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Solenski, Nina, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Neurology.

Urban, Lori, Ph.D., Psychologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Psychology.

Vilar, Nancy, M.D., Ophthalmologist in the Department of Ophthalmology; Attending Staff Status; Period of Reappointment: June 2, 2021, through April 29, 2023; Privileged in Ophthalmology.

Vizzini, Samantha, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: June 1, 2021, through March 30, 2023; Privileged in Anesthesiology.

Waggoner-Fountain, Linda, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Pediatrics.

Williams, Michael A., M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Pediatrics.

Williams, Michael D., M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Surgery.

Wilson, Barbara, M.D., Dermatologist in the Department of Dermatology; Attending Staff Status; Period of Reappointment: May 31, 2021, through October 29, 2021; Privileged in Dermatology.

Varney, Catherine, D.O., Physician in the Department of Family Medicine; Attending Staff Status; Period of Reappointment: June 1, 2021, through February 1, 2022; Privileged in Family Medicine.

Zhu, Xiaoying, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Anesthesiology.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Caley, Matthew R., M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Effective Date of Resignation: April 2, 2021.

Dhaliwal, Vishawdeep Singh, D.D.S., Dentist in the Department of Dentistry; Attending Staff Status; Effective Date of Resignation: April 13, 2021.

Pourafshar, Negiin, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Effective Date of Resignation: March 31, 2021.

Squires, James E., M.D., Pediatric Gastroenterologist in the Department of Medicine; Attending Staff Status; Effective Date of Resignation: April 29, 2021.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the granting of privileges to the following Advanced Practice Providers are approved:

Campo, Jenna R., R.N., N.P., Adult Gerontology Primary Care Nurse Practitioner in the Department of Medicine; Period of Privileging: May 2, 2021 through May 1, 2022; Privileged as an Adult Gerontology Primary Care Nurse Practitioner.

Chvanov, David, R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: May 3, 2021 through May 2, 2022; Privileged as an Adult Gerontology Acute Care Nurse Practitioner.

Merrel, Paul Kent, C.N.S., Clinical Nurse Specialist in the Department of Medicine; Period of Privileging: May 7, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Morgan, Rachel K., P.A., Physician Assistant in the Department of Otolaryngology; Period of Privileging: April 15, 2021 through March 31, 2022; Privileged as a Physician Assistant.

Stubbs, Emily J., R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Period of Privileging: May 3, 2021 through May 2, 2022; Privileged as a Family Nurse Practitioner.

Sweitzer, Karen, P.A., Physician Assistant in the Department of Medicine; Period of Privileging: June 1, 2021 through May 31, 2022; Privileged as a Physician Assistant.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the renewal of privileges to the following Advanced Practice Providers are approved:

Booth, Caleb, P.A.., Physician Assistant in the Department of Radiology and Medical Imaging; Period of Privileging: June 18, 2021 through June 17, 2023; Privileged as a Physician Assistant.

Brady, Carolyn A., R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: June 3, 2021 through June 2, 2023; Privileged as an Acute Care Nurse Practitioner.

Exline, Charlene G., R.N., N.P., Family Nurse Practitioner in the Department of Neurosurgery; Period of Privileging: June 21, 2021 through June 20, 2023; Privileged as a Family Nurse Practitioner.

Floyd, Shawn., R.N., N.P., Acute Care Nurse Practitioner in the Departments of Medicine and Surgery; Period of Privileging: June 18, 2021 through June 17, 2023; Privileged as an Acute Care Nurse Practitioner.

Ficht, Stephanie, R.N., N.P., Neonatal Nurse Practitioner in the Department of Pediatrics; Period of Privileging: June 29, 2021 through June 28, 2023; Privileged as a Neonatal Nurse Practitioner.

Hildebrand, Debra L., AuD, Audiologist in the Department of Otolaryngology; Period of Privileging: June 1, 2021 through June 30, 2023; Privileged as an Audiologist.

Koch, Emily D., R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: May 21, 2021 through May 20, 2023; Privileged as an Acute Care Nurse Practitioner.

Muncaster Larkin E., R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Period of Privileging: June 7, 2021 through June 6, 2023; Privileged as a Family Nurse Practitioner.

Otto, Michelle W., R.N., N.P., Adult Nurse Practitioner in the Department of Medicine; Period of Privileging: June 16, 2021 through June 15, 2023; Privileged as an Adult Nurse Practitioner.

Myers, Lara T., R.N., N.P., Acute Care Nurse Practitioner in the Departments of Neurosurgery and Surgery; Period of Privileging: May 1, 2021 through April 30, 2023; Privileged as an Acute Care Nurse Practitioner.

Reck, Abril D., R.N., N.P., Family Nurse Practitioner in the Department of Family Medicine; Period of Privileging: June 1, 2021 through May 31, 2023; Privileged as a Family Nurse Practitioner.

Sennett, Margaret M., R.N., N.P., Pediatric Nurse Practitioner in the Department of Pediatrics; Period of Privileging: July 1, 2021 through June 30, 2023; Privileged as a Pediatric Nurse Practitioner.

Tetro, Pamela A., R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Period of Privileging: June 6, 2021 through June 5, 2023; Privileged as a Family Nurse Practitioner.

Trapp, Mackenzie, G.C., Genetic Counselor in the Department of Pediatrics; Period of Privileging: July 1, 2021 through June 30, 2023; Privileged as a Genetic Counselor.

Wielar, Amy J., R.N., N.P., Certified Registered Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: June 28, 2021 through June 27, 2023; Privileged as a Certified Registered Nurse Anesthetist.

Wood, Caitlin, P.A., Physician Assistant in the Department of Pediatrics; Period of Privileging: June 15, 2021 through June 14, 2023; Privileged as a Physician Assistant.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Advanced Practice Provider is approved:

Crovo, Dustin M., R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: March 30, 2021.

Hendrix, Ann., R.N., N.P., Certified Registered Nurse Anesthetist in the Department of Anesthesiology; Effective Date of Resignation: March 4, 2021.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for new procedural privileges to the following Advanced practice Providers are approved:

Barnes, Kierah, R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Surgery. Additional Privileges for CALS, Epicardial Pacing Wire Removal, Arterial Lines, Bronchoscopy, Central Line Insertion, Chest Tube Removal and IABP Removal. Effective Date: May 4, 2021, through February 27, 2023.

Compton, Rebekah, R.N., N.P., Family Nurse Practitioner in the Department of Family Medicine. Additional Privileges for NP Autonomous Practice. Effective Date: May 4, 2021, through November 26, 2021.

McGee-White, Marcia, R.N., N.P., Neonatal Nurse Practitioner in the Department of Pediatrics. Additional Privileges for Performance of Endotracheal Intubation; Insertion & Management of Peripherally inserted central Lines (PICC) lines with and without ultrasound with the exception of jugular and femoral veins – SCALP-posterior auricular, superficial, temporal, occipital, supratrochlear, supraorbital; Insertion and management of umbilical arterial and umbilical venous catheters. Effective Date: May 4, 2021, through January 10, 2022.

Shannon, Kristine G., R.N., N.P., Family Nurse Practitioner in the Department of Family Medicine. Additional Privileges for NP Autonomous Practice. Effective Date: May 4, 2021, through November 24, 2021.

Sorensen, Eric, R.N., N.P., Acute Care Nurse Practitioner in the Department of Emergency Medicine. Additional Privileges for NP Autonomous Practice. Effective Date: May 4, 2021, through August 15, 2021.

CREDENTIALING AND RECREDENTIALING ACTIONS – HEALTH SYSTEM BOARD/ TRANSITIONAL CARE HOSPITAL – APPROVED JUNE 3, 2021

RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:

Grundy, Brian, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: April 23, 2021, through June 30, 2021; Privileged in Surgery.

Kaiser, Talal, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Appointment: May 13, 2021, through June 30, 2021; Privileged in Surgery.

RESOLVED the recommendations of the Clinical Staff Executive Committee for reappointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:

Angle, John, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Radiology and Medical Imaging.

Brockmeier, Stephen, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Orthopedic Surgery.

Dalkin, Alan, M.D., Endocrinologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Daniero, James, M.D., Otolaryngologist in the Department of Otolaryngology; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Otolaryngology.

Flannagan, Molly, M.D., Surgeon in the Department of Surgery; Consulting Staff Status; Period of Reappointment: June 1, 2021, through December 30, 2022; Privileged in Surgery.

Hoke, George, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Ling, David, M.D., Physician in the Department of Medicine; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Martin, Benjamin, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Mazimba, Sula, M.D., Cardiologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Purow, Benjamin, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Neurology.

Sneed, Benjamin, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Medicine.

Solenski, Nina, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Neurology.

Williams, Michael, M.D., Surgeon in the Department of Surgery; Consulting Staff Status; Period of Reappointment: May 31, 2021, through May 30, 2023; Privileged in Surgery.

Wilson, Barbara, M.D., Dermatologist in the Department of Dermatology; Consulting Staff Status; Period of Reappointment: May 31, 2021, through October 29, 2021; Privileged in Dermatology.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Pourafshar, Negiin, M.D., Nephrologist in the Department of Medicine; Consulting Staff Status; Effective Date of Resignation: March 31, 2021.

Santen, Richard J., M.D., Endocrinologist in the Department of Medicine; Consulting Staff Status; Effective Date of Resignation: April 29, 2021.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the renewal of privileges to the following Allied Health Professionals are approved:

Booth, Caleb, P.A., Physician Assistant in the Department of Radiology and Medical Imaging; Period of Privileging: June 18, 2021 through June 17, 2023; Privileged as a Physician Assistant.

Floyd, Shawn, R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: June 18, 2021 through June 17, 2023; Privileged as an Acute Care Nurse Practitioner.

Hildebrand, Debra L., AuD., Audiologist in the Department of Otolaryngology; Period of Privileging: July 1, 2021 through June 30, 2023; Privileged as an Audiologist.

CREDENTIALING AND RECREDENTIALING ACTIONS – HEALTH SYSTEM BOARD – APPROVED APRIL 20, 2021

RESOLVED, pursuant to the delegation of authority contained in the September 15, 2011 Resolution of the Medical Center Operating Board, the undersigned hereby approve the following Credentialing and Recredentialing Actions as specifically set forth below:

Miller, Stephen, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Appointment: April 5, 2021, through April 4, 2022; Privileged in Obstetrics and Gynecology.

Salpini, Emily, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Appointment: May 1, 2021, through April 30, 2022; Privileged in Pediatrics.

Scott, Christopher, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Appointment: March 18, 2021, through March 17, 2022; Privileged in Surgery.

Becker, Daniel, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Brenin, David, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Surgery.

Cropley, Thomas, M.D., Dermatologist in the Department of Dermatology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Dermatology.

Dameron, Zachariah, M.D., Psychiatrist in the Department of Psychiatry and Neurobehavioral Sciences; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Psychiatry and Neurobehavioral Sciences.

Dean, Peter, M.D., Pediatric Cardiologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Pediatrics.

Donowitz, Gerald, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Dudley, Donald, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Obstetrics and Gynecology.

Farivar, Behzad, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: May 4, 2021, through September 29, 2022; Privileged in Surgery.

Felder, Robin, Ph.D., Pathologist in the Department of Pathology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Pathology.

Galbraith, Ted, D.D.S., Dentist in the Department of Dentistry; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Dentistry.

Gampper, Thomas, M.D., Plastic Surgeon in the Department of Plastic Surgery; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Plastic Surgery.

Gentzler, Ryan, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Goodkin, Howard, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Neurology.

Gypson, Ward, M.D., Physiatrist in the Department of Physical Medicine and Rehabilitation; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Physical Medicine and Rehabilitation.

Herrera, Jenniffer, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Pediatrics.

Horbaly, William, D.D.S., Dentist in the Department of Dentistry; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Dentistry.

Hullfish, Kathie, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Obstetrics and Gynecology.

Ibanez, Carlos, D.D.S.., Dentist in the Department of Dentistry; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Dentistry.

Intagliata, Nicolas, M.D., Gastroenterologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Iqbal, Ausia, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Janowski, Einsley-Maria, M.D., Ph.D., Radiation Oncologist in the Department of Radiation Oncology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Radiation Oncology.

Johnson, Jonathan, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Neurology.

Kesser, Bradley, M.D., Otolaryngologist in the Department of Otolaryngology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Otolaryngology.

Kyaw, Thurein, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Landes, Daniel, M.D., Otolaryngologist in the Department of Otolaryngology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Otolaryngology.

Lee, Meredith, D.O., Psychiatrist in the Department of Psychiatry and Neurobehavioral Sciences; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Psychiatry and Neurobehavioral Sciences.

Lobo, Peter, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Luckey, Chance, M.D., Pathologist in the Department of Pathology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Pathology.

Manson, William, M.D., Anesthesiology in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Anesthesiology.

Moorman, Joseph, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Morgan, Raymond, M.D., Plastic Surgeon in the Department of Plastic Surgery; Administrative Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023.

Nathan, Barnett, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Neurology.

Nguyen, Jonathan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Radiology and Medical Imaging.

Parsons, Andrew, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Plews-Ogan, Margaret, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Rao, Swati, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Royer, Regan, M.D., Physiatrist in the Department of Physical Medicine and Rehabilitation; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Physical Medicine and Rehabilitation.

Santen, Richard, M.D., Endocrinologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Sinkin, Robert, M.D., Neonatologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Pediatrics.

Smith, Justin, M.D., Neurosurgeon in the Department of Neurosurgery; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Neurosurgery.

Thom, Mary, M.D., Physician in the Department of Emergency Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Emergency Medicine.

Yarboro, Seth M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Orthopedic Surgery.

Yemen, Terrance, M.D., Anesthesiology in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Anesthesiology.

Young, Kenan, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Surgery.

Zanelli, Santina, M.D., Neonatologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Pediatrics.

Zlotoff, Barrett, M.D., Dermatologist in the Department of Dermatology; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Dermatology.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the secondary appointment to the clinical staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioner are approved:

Zlotoff, Barrett, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Secondary Reappointment: April 30, 2021, through April 29, 2023; Privileged in Pediatrics.

Varney, Catherine, D.O., Physician in the Department of Surgery; Attending Staff Status; Period of Secondary Reappointment: April 19, 2021, through April 18, 2022; Privileged in Surgery.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Asrar, Luna, M.D., Physician in the Department of Family Medicine; Attending Staff Status; Effective Date of Resignation: March 17, 2021.

Golden, Wendy, Ph.D., Pathologist in the Department of Pathology; Attending Staff Status; Effective Date of Retirement: December 31, 2020.

Uppal, Dushant, M.D., Gastroenterologist in the Department of Medicine; Attending Staff Status; Effective Date of Resignation: January 31, 2021.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the granting of privileges to the following Advanced Practice Providers are approved:

Blevins, Cheri S., R.N., N.P., Clinical Nurse Specialist in the Department of Medicine; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Bridy, Adrian, R.N., N.P., Certified Registered Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: April 19, 2021 through April 18, 2022; Privileged as a Certified Registered Nurse Anesthetist.

Darrah, Timothy S., R.N., N.P., Clinical Nurse Specialist in the Department of Medicine; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Elgin, Kimberly W., R.N., N.P., Clinical Nurse Specialist in the Department of Surgery; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Frase, Kathy J., R.N., N.P., Certified Registered Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: April 5, 2021 through April 4, 2022; Privileged as a Certified Registered Nurse Anesthetist.

Gillan, Stephanie M., R.N., N.P., Family Nurse Practitioner in the Department of Neurology; Period of Privileging: March 22, 2021 through March 21, 2022; Privileged as a Family Nurse Practitioner.

Johnston, Amy., R.N., N.P., Clinical Nurse Specialist in the Department of Psychiatry and Neurobehavioral Sciences; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Kimpel-Wilkins, Kristi., R.N., N.P., Clinical Nurse Specialist in the Department of Surgery; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Longley, Christine M., R.N., N.P., Clinical Nurse Specialist in the Department of Medicine; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Mahanes, Dea D., R.N., N.P., Clinical Nurse Specialist in the Department of Psychiatric and Neurobehavioral Sciences; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Miller, Kimberly D., R.N., N.P., Clinical Nurse Specialist in the Department of Medicine; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Queheillalt, Suzanne, R.N., N.P., Clinical Nurse Specialist in the Department of Surgery; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Rea, Kathleen., R.N., N.P., Clinical Nurse Specialist in the Department of Surgery; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Simmons, Amanda K., R.N., N.P., Clinical Nurse Specialist in the Department of Medicine; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Thomas, Tanya D., R.N., N.P., Clinical Nurse Specialist in the Department of Medicine; Period of Privileging: April 1, 2021 through March 31, 2022; Privileged as a Clinical Nurse Specialist.

Wunderlich, Jessica., R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Period of Privileging: March 22, 2021 through March 21, 2022; Privileged as a Family Nurse Practitioner.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the renewal of privileges to the following Advanced Practice Providers are approved:

Adams, Deborah M., P.A.., Physician Assistant in the Department of Medicine; Period of Privileging: May 14, 2021 through May 13, 2023; Privileged as a Physician Assistant.

Dean, Ann E., R.N., N.P.., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: May 14, 2021 through May 13, 2023; Privileged as an Acute Care Nurse Practitioner.

Dubose, Laura R., R.N., N.P.., Adult Gerontology Acute Care Nurse Practitioner in the Department of Neurology; Period of Privileging: May 7, 2021 through January 9, 2022; Privileged as an Adult Gerontology Acute Care Nurse Practitioner.

Gyampoh, Julia, R.N., N.P.., Adult Gerontology Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: May 3, 2021 through May 2, 2023; Privileged as an Adult Gerontology Acute Care Nurse Practitioner.

Harrison, Nancy J., R.N., N.P., Certified Registered Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: May 14, 2021 through May 13, 2023; Privileged as a Certified Registered Nurse Anesthetist.

Hite, Catherine, R.N., N.P., Family Nurse Practitioner in the Department of Surgery; Period of Privileging: May 21, 2021 through May 20, 2023; Privileged as a Family Nurse Practitioner.

Mahoney, Traci L., P.A., Physician Assistant in the Department of Orthopedic Surgery; Period of Privileging: May 21, 2021 through May 20, 2023; Privileged as a Physician Assistant.

Papik, Jenna, R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Period of Privileging: May 14, 2021 through May 13, 2023; Privileged as a Family Nurse Practitioner.

Parente, Kelsey M., P.A., Physician Assistant in the Department of Orthopedic Surgery; Period of Privileging: May 21, 2021 through May 20, 2023; Privileged as a Physician Assistant.

Towner, Shelley, G.C., Genetic Counselor in the Department of Pediatrics; Period of Privileging: June 1, 2021 through May 31, 2023; Privileged as a Genetic Counselor.

Tucker, Shannon E., P.A., Physician Assistant in the Department of Surgery; Period of Privileging: May 4, 2021 through May 3, 2023; Privileged as a Physician Assistant.

Wilson, Chad B., P.A., Physician Assistant in the Department of Orthopedic Surgery; Period of Privileging: June 1, 2021 through May 31, 2023; Privileged as a Physician Assistant.

Wilson, Jacquelyn N., P.A., Physician Assistant in the Department of Orthopedic Surgery; Period of Privileging: June 1, 2021 through May 31, 2023; Privileged as a Physician Assistant.

White, Andrea M., P.A., Physician Assistant in the Department of Orthopedic Surgery; Period of Privileging: May 19, 2021 through May 18, 2023; Privileged as a Physician Assistant.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Advanced Practice Provider is approved:

Reagan, April, R.N., N.P., Certified Nurse Midwife in the Department of Obstetrics and Gynecology; Effective Date of Resignation: April 4, 2021.

Fisher, Charles A., R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: March 17, 2021.

Miller, Grace, R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: February 17, 2021.

Schwartz, Linda L., P.A., Physician Assistant in the Department of Pediatrics; Effective Date of Resignation: February 6, 2021.

Winer, Ann H., R.N., N.P., Certified Registered Nurse Anesthetist in the Department of Anesthesiology; Effective Date of Retirement: March 7, 2021.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for new procedural privileges to the following Advanced practice Providers are approved:

Barqadle, Halima, R.N., N.P., Certified Nurse Midwife in the Department of Obstetrics and Gynecology. Additional Privileges for Labor Management – Induction of Labor after consultation with physician; Postpartum Management; Management of normal spontaneous birth with the collaborating physician or designee readily available; repair of first second- degree perineal lacerations and other associated lacerations; postpartum management-monitoring vital signs, lochia, fundus and bladder function in the immediate postpartum period; and interpretation of fetal monitoring tracing. Effective Date: April 6, 2021, through November 30, 2021.

Galuppo, Jana, P.A., Physician Assistant in the Department of Neurology. Additional Privileges for Botox Injections. Effective Date: April 6, 2021, through October 15, 2021.

CREDENTIALING AND RECREDENTIALING ACTIONS – HEALTH SYSTEM BOARD/ TRANSITIONAL CARE HOSPITAL – APPROVED APRIL 28, 2021

Scott, Christopher, M.D., Surgeon in the Department of Surgery; Consulting Staff Status; Period of Appointment: March 18, 2021, through March 17, 2021; Privileged in Surgery.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for reappointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:

Cropley, Thomas, M.D., Dermatologist in the Department of Dermatology; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Dermatology.

Donowitz, Gerald, M.D., Physician in the Department of Medicine; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Gampper, Thomas, M.D., Plastic Surgeon in the Department of Plastic Surgery; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Plastic Surgery.

Gypson, Ward, M.D., Physiatrist in the Department of Physical Medicine and Rehabilitation; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Physical Medicine and Rehabilitation.

Iqbal, Ausia, M.D., Physician in the Department of Medicine; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Nathan, Barnett, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Parsons, Andrew, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Plews-Ogan, Margaret, M.D., Physician in the Department of Medicine; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Rao, Swati, M.D., Nephrologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Royer, Regan, M.D., Physiatrist in the Department of Physical Medicine and Rehabilitation; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Physical Medicine and Rehabilitation.

Smith, Anna, M.D., Allergist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: May 8, 2021, through June 29, 2022; Privileged in Medicine.

Smith, Justin, M.D., Neurosurgeon in the Department of Neurosurgery; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Medicine.

Yarboro, Seth, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Orthopedic Surgery.

Zlotoff, Barrett, M.D., Dermatologist in the Department of Dermatology; Consulting Staff Status; Period of Reappointment: April 30, 2021, through April 29, 2023; Privileged in Dermatology.

RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Caley, Matthew R., M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Effective Date of Resignation: April 2, 2021.

Gaare, Meghan E., M.D.., Psychiatrist in the Department of Psychiatry and Neurobehavioral Sciences; Consulting Staff Status; Effective Date of Resignation: March 30, 2021.

	Division	Audit Topic	Audit Scope
1	UVA Health	Case Management/ Utilization Management (In Progress)	Analyze claims data for length of stay opportunities and compliance risk indicators. Assess Case Management and Utilization Management activities for compliance with established policies and opportunities for improvement.
2	UVA Health	Supplies Procurement (In Progress)	Evaluate purchasing and receiving controls for medical supplies
3	UVA Health	Charge Capture – Mosaiq (In Progress)	Assess charge capture controls for charges interfaced between Mosaiq and Epic systems
4	UVA Health	Provider Based Billing Compliance	Test for compliance with billing rules for provider-based clinics
5	UVA Health	Time Keeping and Payroll	• Unauthorized financial transactions • Excessive payroll costs
6	UVA Health	Purchase Card Controls	• Unauthorized transactions • Potential for internal theft/fraud
7	UVA Health	Emergency Department E&M Levels	• Revenue loss • Non-compliant claims
8	UVA Health	Insurance Verification and Pre-Authorization	Denials and rework
9	UVA Health	Status Assignment	• Non-compliant claims • Loss of revenue • Denials
10	UVA Health	Controlled Substances Diversion Program	Effectiveness of diversion controls established after prior internal audit.
11	UVA Health	Data Warehouse Controls	Information Security and Privacy
12	UVA Health	Pharmacy Department Charge Capture	Assess charge capture controls for Pharmacy including Pharmacy 340B
12	UVA Health	Epic Provisioning and De-provisioning—clinical areas	• Identity and Access Management • Information Security and Privacy
1	Pan-University	Cybersecurity	Follow-up on status of 2019 KPMG Cybersecurity Assessment recommendations.
2	Pan-University	Safety and Security	Implementation status of recommendations in the 2017 MH consulting report.
3	Pan-University	Research Data Security	Information security for non-centrally managed research data systems.
1	Academic	Advancement Payment Processing (In Progress)	Assessment of controls over processes outsourced by Advancement to CDS Global.
2	Academic	Section 117 of the Higher Education Act Reporting	Implementation of process improvement recommendations arising from limited scope procedures performed previously.
3	Academic	Rebates and Credits Related to Sponsored Awards	Implementation of process improvement recommendations arising from prior procedures.
4	Academic	CARES Compliance - Research (2020 OMB Supplement and Addendum, Memorandum 20-17)	Processes for applying administrative relief granted by OMB to address COVID-19 related loss of operational capacity and increased costs.
5	Academic	CARES Compliance - Higher Education Emergency Relief Fund (HEERF I, II, III)	Controls and processes related to HEERF funds data collection, use, accounting, and reporting.
6	Academic	Cash Deficit Management Process (In Progress)	University policies, practices, and tools for monitoring and managing unit cash deficits.
7	Academic	NCAA Compliance (Integrated Assurance)	Refresh reliance on UVA Athletics Department Compliance Office by evaluating monitoring procedures for at least one major compliance area.
8	Academic	Student Health & Counseling	Student health and counseling services (includes Elson Student Health, Women's Center, Sheila Johnson Center, McCue Center)
9	Academic	Undergraduate Student Advising	Accuracy, completeness, availability, and usage (data analytics) of information for students, faculty, advisors, parents, and other constituents about the advising process; technology used in support of advising processes; training and continuing development required for advisors. (COSO Principle 13)
10	Academic	Study Enabling Technologies	Use of Artificial Intelligence (AI) in Instructional Technologies
11	Academic	Finance Strategic Transformation (FST) - Project Health Checks (In Progress)	Ongoing project health checks approximately every 2 months through July 2022 Workday Financials go-live.
12	Academic	FST - Internal Control Framework (In Progress)	Advise UVA Finance and Baker Tilly in development and documentation of internal controls framework related to Workday implementation
13	Academic	Construction Projects: Hotel and Conference Center Physics Building Renovation Hospital Expansion Project Closeout (In Progress) Ivy Mountain Musculoskeletal Clinic (In Progress)	Using an outside expert in construction project management accounting, perform procedures relevant to phase of specified construction projects
14	Academic	International Operations - Phase 1: Inventory of Activities	Develop inventory of international activities to determine eventual audit scope
15	Academic	Academic Records and Policies	Processes for ensuring undergraduate and graduate records convey quality information (complete, accurate, timely, available) for students and others who use them. (COSO Principle 13)
16	Academic	Institutional Data	Processes for ensuring statistical data used in external reporting conveys quality information (complete, accurate, timely, available). Includes UVA website (info for prospective students and parents), US News and World Report, National Study of Instructional Cost & Productivity (Delaware Cost Study), IPEDS, SCHEV, etc. (COSO Principle 13)

	Division	Audit Topic	Audit Scope
1	UVA Health	Financial Assistance and Financial Counseling	Potential revenue loss, Patient satisfaction, compliance with Virginia Debt Collection Act
2	UVA Health	Denials Management	Potential for revenue loss
3	UVA Health	Point of Service Collections	Fraud controls and potential for revenue loss
4	UVA Health	Patient Choice Compliance	Compliance with relevant CMS regulations
5	UVA Health	Funds Flow-Department of Medicine	Conformance of transactions with relevant Memorandum of Understanding
6	UVA Health	Discharge Planning	Readmissions; length of stay; CMS regulatory compliance (Conditions of Participation)
7	UVA Health	IT Disaster Recovery	Risks to operational continuity posed by IT interruptions
8	UVA Health	Contract Management	Controls over contract management
9	UVA Health	Telehealth Coding and Billing Compliance	Potential for non-compliant claims, loss of revenue, denials
10	UVA Health	Balance Billing	Compliance with new regulatory requirements around out-of-network provider billing
11	UVA-Novant JOC	Specific topic TBD	Dependent on integration details and risk assessment
12	UVA Health and Academic Division	Distributed Information Systems Management	Information security practices for non-centrally managed IT systems or networks (School of Medicine, School of Nursing, School of Data Science)
1	Pan-University	Cybersecurity	Follow-up on Mandiant assessment (2021) and recommendations for ransomware and malware readiness/response
2	Pan-University	Human Resources Benefit Plans Administration	Controls related to benefit plan administration (specific plan(s) to be determined).
1	Academic	International Operations	Assessment of higher priority international activities identified in Phase 1.
2	Academic	School Level Audit(s)	Effectiveness of key unit/school level controls and processes.
3	Academic	Student Information System (SIS) Business and IT Controls	Controls over the Student Information System, the system of record for all student-related information including class enrollment, teaching and exam schedules, unofficial transcripts and grades, and student finance.
4	Academic	Workday Financials Controls Validation	Effectiveness of key financial and access controls post Workday Financials go-live
5	Academic	Emergency Preparedness & Safety - Public Health Annex	Alignment of pandemic response activities to Critical Incident Management Plan Public Health Annex.
6	Academic	Auxiliary Services	Housing Department processes and controls
7	Academic	Student Financial Aid	Processes and controls to ensure compliance with Gramm Leach Bliley Act (GLBA) requirements for safeguarding customer information.
8	Academic	Police Department	Training beyond Basic Training, which will be reviewed this summer during CALEA accreditation visit.

Internal Auditing is an independent, objective assurance and consulting activity designed to add value and improve an organization’s operations. It helps an organization accomplish its objectives by bringing a systematic, disciplined approach to evaluate and improve the effectiveness of risk management, control, and governance processes. The UVA Office of Audit and Compliance assists UVA’s Board of Visitors and University management in the discharge of their oversight, management, and operating responsibilities by providing independent assurance and consulting services to the University community. Our services add value by improving the control, risk management and governance processes to help the University achieve its business objectives.

It is the policy of the of the University to establish and support the Office of Audit and Compliance to assist the University in accomplishing its objectives by bringing a systematic and disciplined approach to evaluate and improve the effectiveness of the University’s governance, risk management, and internal controls. The internal audit activity’s responsibilities are defined by the Audit, Compliance, and Risk Committee (ACR Committee) of the Board of Visitors (Board) as part of its oversight role.

The internal auditor, with strict accountability for confidentiality and safeguarding records and information, is authorized to have full, free, and unrestricted access to any and all of the University’s records, physical properties, and personnel pertinent to carrying out an engagement.

All employees are requested to assist the Audit Department in fulfilling its roles and responsibilities. The internal audit activity will also have free and unrestricted access to the ACR Committee and its chairman.

The Chief Audit Executive will report on behalf of the internal audit activity ~~(functionally)~~ to the ACR Committee chairman, and administratively (day to day operations) to the ~~President~~ Executive Vice President and Chief Operating Officer of the University.

The Chief Audit Executive will communicate and interact directly with the ACR Committee, including in executive sessions and between ACR Committee meetings as appropriate.

Institute of Internal Auditors’ mandatory guidance, which includes the Core Principles for the Professional Practice of Internal Auditing, the Code of Ethics, the International Standards for the Professional Practice of Internal Auditing, and the Definition of Internal Auditing.

The Office of Audit and Compliance will adhere to the University’s relevant policies and procedures as well as the Generally Accepted Governmental Auditing Standards of the Government Accountability Office.

The Office of Audit and Compliance will continuously strive to be effective by operating in a manner consistent with the IIA’s Core Principles:

The internal audit activity will remain free from interference by any element in the University, including matters of audit selection, scope, procedures, frequency, timing, or report content to permit maintenance of a necessary independent and objective function. The Chief Audit Executive must disclose such interference to the ACR Committee and discuss the implications.

Internal auditors will have no direct operational responsibility or authority over any of the activities audited. Accordingly, they will not implement internal controls, develop procedures, install systems, prepare records, or engage in any other activity that may impair internal auditors’ independence or judgment. Internal auditors may provide assurance services for areas previously consulted, provided the consulting services did not impair objectivity.

Internal auditors will exhibit the highest level of professional objectivity in gathering, evaluating, and communicating information about the activity or process being examined. Internal auditors will make a balanced assessment of all the relevant circumstances and not be unduly influenced by their own interests or by others in forming judgments.

The Chief Audit Executive will annually evaluate reporting lines and responsibilities and confirm to the ACR Committee the organizational independence of the Office of Audit and Compliance.

The scope of internal auditing encompasses, but is not limited to, the examination and evaluation of the adequacy and effectiveness of the University’s governance, risk management, and internal controls as well as the quality of performance in carrying out assigned responsibilities to achieve the University’s stated goals and objectives. This includes:

At least annually, the Chief Audit Executive will submit to senior management and the ACR an internal audit plan for review and approval. The internal audit plan will consist of a work schedule as well as budget and resource requirements for the next year. The Chief Audit Executive will communicate the impact of resource limitations and significant interim changes to senior management and the Board.

The internal audit plan will be developed based on a prioritization of the audit universe using a risk-based methodology, including input of senior management, the ACR, and Board.

The Chief Audit Executive will review and adjust the plan, as necessary, in response to changes in the organization’s business, risks, operations, programs, systems, and controls. Any significant deviation from the approved internal audit plan will be communicated to senior management and the ACR through periodic activity reports.

The Chief Audit Executive is empowered to conduct assurance services, special audit projects, reviews, or investigations at the request of the Board, ACR Committee, President, General Counsel, EVP Provost, EVP Chief Operating Officer, EVP Health Affairs, or their designee, to assist management in meeting its objectives, promoting economy and efficiency in the administration of, or preventing and detecting fraud and abuse in its programs and operations. The Office of Audit and Compliance may also provide consulting services, beyond assurance services, to assist management in meeting its objectives. Examples may include facilitation, process design, training, and advisory services.

The Chief Audit Executive, with the goal of avoiding duplication of work, will coordinate the office’s audit efforts with those of the Commonwealth of Virginia’s Auditor of Public Accounts, or other external auditing agencies as applicable, by participating in the planning and definition of the scope of proposed audits so the work of all auditing groups is complementary and their combined efforts provide comprehensive, cost- effective audit coverage for the University.

A written report will be prepared and issued by the Chief Audit Executive or designee following the conclusion of each internal audit engagement and will be distributed as appropriate. Internal audit results will be available for review by the ACR and the Board of Visitors.

The internal audit report will include management’s response and corrective action taken or to be taken regarding the specific findings and recommendations.

Management's response to audit findings and recommendations should include a timetable for anticipated completion of action to be taken and an explanation for any corrective action that will not be implemented.

The Office of Audit and Compliance will be responsible for appropriate follow-up on its engagement findings and recommendations. All significant findings will remain in an open issues file until cleared. The ACR will receive periodic reporting from the Chief Audit Executive on the status of management’s action plan implementation.

The Chief Audit Executive will periodically report to senior management and the ACR on the internal audit activity’s purpose, authority, and responsibility, as well as performance relative to its plan. Reporting will also include significant risk exposures and control issues, including fraud risks, governance issues, and other matters needed or requested by senior management, ACR, or the Board.

In alignment with the IIA Standards the Chief Audit Executive must develop and maintain a quality assurance and improvement program that covers all aspects of the internal audit activity. The program must include both internal and external assessments to evaluate the internal audit activity’s conformance with the Standards and an evaluation of whether internal auditors abide by the Code of Ethics.

Internal assessments are conducted at the conclusion of each engagement in accordance with the quality standards described in greater detail in the Internal Audit Policies and Procedures Manual. The results of ongoing internal assessments are communicated to the ACR on an annual basis.

External assessments must be conducted at least once every five years by a qualified independent assessor or assessment team from outside the organization.

The program will also assess the efficiency and effectiveness of the internal audit activity and identify opportunities for improvement. The Chief Audit Executive must communicate results of the quality assurance and improvement program to senior management and the ACR Committee.

5 The relevant portion of the BoV resolution reads: WHEREAS, in recent years the University community has undertaken a reexamination of its past and has removed or renamed a number of symbols of unequal treatment of racial minorities on Grounds. Efforts have included changing the names of several buildings, removing the Confederate War Memorial plaques from the Rotunda, constructing the Memorial to Enslaved Laborers, and naming a residence hall for a formerly enslaved couple who lived and worked at the University; and

WHEREAS, the inscription on the Whispering Wall celebrating the Confederacy is a symbol of support for slavery and inequality;

RESOLVED, the Board of Visitors requests that the University Committee on Names undertake to determine if rededication of the Hume Memorial Wall is appropriate and feasible, or if the memorial should be removed, and make a final recommendation to the Board at a future meeting (09 20 meeting, p.11498).

7 The Committee’s recommendation has involved wide community consultation via emails, a web portal with a community comment feature (https://namingandmemorials.president.virginia.edu/), telephone conversations with concerned individuals and representatives of organizations, and a formal public listening session. We are grateful to all those who shared their thoughtful comments with us.

	Actual as of 06/30/21	Approved as of 07/01/21
Salary	$772,500	$811,125
Deferred Compensation	$150,000	$150,000
One-Time Bonus	-	$200,000⁴

2021-2022 SALARY FOR PRESIDENT JAMES E. RYAN

President James E. Ryan

Were our recommendation accepted, all future University publications, whether printed or electronic, should henceforth refer to the site as the Whispering Wall. The name “Hume Memorial” should no longer to be used.

4. SPECIAL SALARY ACTIONS

5. RESIGNATIONS

6. RETIREMENTS

12. ELECTION OF PROFESSORS EMERITI

14. ELECTION OF ASSOCIATE PROFESSORS EMERITI

19. RETIREMENTS

20. ELECTION OF PROFESSORS EMERITI

6 The text of the inscription reads: “A MEMORIAL TO THE HONORABLE FRANK HUME

BORN CULPEPPER JULY 21, 1843 DIED WASHINGTON, D.C. JULY 18, 1906

A DEVOTED VIRGINIAN WHO SERVED HIS NATIVE STATE IN CIVIL WAR AND LEGISLATIVE HALL”